Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cardiac Hypertrophic Response WP2795,0.000214024946432304,3.1119825708061004,26.29444147981805,"['MAP2K3', 'HDAC4', 'MAP2K1', 'CAMK2D', 'MAP3K1', 'CHUK', 'PDPK1', 'MAPK14', 'FGF2', 'HDAC9', 'TGFBR1', 'HDAC7', 'IKBKB', 'MAPK8', 'AKT2', 'RAF1', 'MAP3K7', 'MAP3K14', 'MAP2K5', 'MAPK3']",0.11707164569847028,0,0,20
2,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.00117527251702196,1.9419585938922956,13.100948318347529,"['PRKAA1', 'SHC3', 'MAPKAP1', 'PIK3R4', 'SLC2A1', 'PRKAG2', 'CBLB', 'PIK3C2A', 'CBL', 'RPTOR', 'RPS6KA3', 'GYS1', 'RPS6KA6', 'MAPK8', 'RPS6KA5', 'AKT2', 'MAP3K9', 'MAP3K7', 'MAP3K4', 'MAP2K5', 'MAPK3', 'MAP4K4', 'MAP2K3', 'MAP3K3', 'PTPN1', 'MAP2K1', 'MAP3K1', 'PDPK1', 'INSR', 'MAPK14', 'MAPK13', 'MLXIPL', 'RPS6KB1', 'RAF1', 'MAP3K13', 'MAP3K14']",0.32143703340550606,0,0,36
3,Insulin Signaling WP481,0.00198862556760322,1.7572969214041747,10.930934334202664,"['PRKAA1', 'SHC3', 'STXBP3', 'STXBP4', 'INPPL1', 'PIK3R4', 'SLC2A1', 'CBLB', 'PIK3C2A', 'CBL', 'IKBKB', 'CYTH3', 'RPS6KA3', 'GYS1', 'RPS6KA6', 'MAPK8', 'RPS6KA5', 'AKT2', 'ENPP1', 'MAP3K9', 'MAP3K7', 'MAP3K4', 'MAP2K5', 'MAPK3', 'MAP4K4', 'MAP2K3', 'MAP3K3', 'PTPN1', 'MAP2K1', 'RAB4A', 'MAP3K1', 'PDPK1', 'INSR', 'SORBS1', 'MAPK14', 'MAPK13', 'INPP4A', 'RPS6KB1', 'RAF1', 'MAP3K13', 'SGK1', 'MAP3K14', 'ARF6']",0.3625927284929871,0,0,43
4,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.0032944092673175217,2.1461850543122627,12.266581648126769,"['MAP2K3', 'HDAC4', 'MAP2K1', 'CAMK2D', 'MYEF2', 'CHUK', 'ROCK1', 'PDPK1', 'MAPK14', 'FGF2', 'HDAC9', 'AGT', 'HDAC7', 'LRP6', 'IKBKB', 'MAPK8', 'AKT2', 'DVL1', 'RAF1', 'PLCB2', 'MAP3K14', 'MAP2K5', 'MAPK3']",0.45051046730567107,0,0,23
5,Glycogen Synthesis and Degradation WP500,0.00503406433219968,2.668445013515436,14.120150445601903,"['GBE1', 'AGL', 'PPP2R2A', 'PPP2R5D', 'PPP2R5C', 'PHKA2', 'HK1', 'PPP2CA', 'PTPA', 'GYS1', 'PHKG1', 'PPP2R1B', 'PPP2R1A', 'PPP2R2B']",0.49175441820941324,0,0,14
6,Proteoglycan biosynthesis WP4784,0.0055734482068804,4.188914910226385,21.739384916725015,"['EXT1', 'EXT2', 'CHSY1', 'B3GAT3', 'IMPAD1', 'XYLT1', 'B3GALT6', 'PAPSS2']",0.49175441820941324,0,0,8
7,Signal transduction through IL1R WP4496,0.006879039105565772,3.2232572115384617,16.049488247631427,"['IKBKB', 'MAP2K3', 'MAPK8', 'TGFB2', 'MAP3K1', 'CHUK', 'IRAK2', 'MAPK14', 'MAP3K7', 'MAP3K14']",0.49175441820941324,0,0,10
8,Tgif disruption of Shh signaling WP3674,0.007192020741636757,inf,inf,"['SMAD2', 'TGIF1', 'FOXG1']",0.49175441820941324,0,0,3
9,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.013147441848614667,3.3505074160811867,14.512816939960164,"['NQO2', 'MAPK8', 'SRXN1', 'GSTP1', 'KEAP1', 'MAPK14', 'MAPK13', 'NFE2L2']",0.6400978935667755,0,0,8
10,Histone Modifications WP2369,0.014310467987922721,2.2570723486216444,9.585253555774774,"['KMT2E', 'SETD2', 'KMT2A', 'SETD6', 'SETD7', 'DOT1L', 'KMT2B', 'SETD1A', 'SETDB2', 'EHMT1', 'ASH1L', 'SETBP1', 'NSD1', 'EZH2']",0.6400978935667755,0,0,14
11,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.014310467987922721,2.2570723486216444,9.585253555774774,"['MAP2K1', 'CHUK', 'AHSA1', 'BCL10', 'CBL', 'MALT1', 'IKBKB', 'DLG1', 'FYN', 'RAF1', 'MAP3K7', 'MAP3K14', 'NCK1', 'MAPK3']",0.6400978935667755,0,0,14
12,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.014809880189763256,2.1683649369053244,9.1341521679104,"['MAP2K3', 'MAP3K3', 'MAP2K1', 'MAP3K1', 'CHUK', 'MAPK14', 'TANK', 'IKBKB', 'MAPK8', 'RPS6KA5', 'IRAK2', 'TAB2', 'MAP3K7', 'MAP3K14', 'MAPK3']",0.6400978935667755,0,0,15
13,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.016442245966792945,2.3945046353177704,9.836388662853551,"['MAP2K3', 'RPS6KA3', 'MAPK8', 'MAP2K1', 'MAP3K1', 'IFI27', 'MAP3K9', 'MAPK14', 'RAF1', 'MAP3K4', 'MAPK3', 'MAPK13']",0.6400978935667755,0,0,12
14,Mesodermal commitment pathway WP2857,0.016897542963697526,1.6789929189614476,6.851276769520263,"['SETD2', 'CTBP2', 'CHRD', 'HTT', 'PPP2CA', 'EPB41L5', 'UBR5', 'CEP250', 'DIP2A', 'PRKACA', 'AMH', 'KDM6A', 'ACVR1', 'SMAD2', 'ATP8B2', 'TET1', 'ELP4', 'TRERF1', 'ACVR2A', 'ADAM19', 'EXT1', 'LATS1', 'EXT2', 'KLF5', 'BHLHE40', 'TCF4', 'BMPR1A', 'NFE2L2']",0.6400978935667755,0,0,28
15,Canonical and non-canonical Notch signaling WP3845,0.018935083256980265,3.0456319636647504,12.081226543679586,"['NOTCH2', 'HEY1', 'CHUK', 'MAML1', 'CNTN6', 'ADAM10', 'PSEN1', 'MAML3']",0.6400978935667755,0,0,8
16,CAMKK2  Pathway WP4874,0.019901180819291438,2.4255157236585014,9.500687389848197,"['HDAC4', 'RPTOR', 'CHRM3', 'STIM1', 'EP300', 'NOS1', 'ARHGEF7', 'RAF1', 'GIT1', 'MAPK3', 'NFE2L2']",0.6400978935667755,0,0,11
17,Regulation of Actin Cytoskeleton WP51,0.020326773132102273,1.5744974379188017,6.133952922108812,"['CYFIP2', 'CHRM3', 'ROCK1', 'CHRM5', 'PDGFB', 'PIK3R4', 'IQGAP1', 'PIK3C2A', 'FGF2', 'FGD1', 'PIK3C2B', 'FGF9', 'CFL2', 'PIP4K2A', 'PIP4K2B', 'PIP4K2C', 'MYH10', 'PAK2', 'WASF2', 'GIT1', 'MAPK3', 'APC2', 'PDGFRA', 'MAP2K1', 'GSN', 'RRAS2', 'SSH2', 'SSH1', 'ARHGEF4', 'ARHGEF1', 'RAF1', 'ARHGEF7', 'VCL']",0.6400978935667755,0,0,33
18,MAPK Signaling Pathway WP382,0.021063550428157145,1.4297862001943635,5.519276703814679,"['LRRK2', 'ARRB1', 'FGF2', 'IKBKB', 'RPS6KA3', 'RPS6KA5', 'PPP3CC', 'FGF9', 'AKT2', 'PRKACA', 'MAP3K7', 'MAP3K4', 'MAP2K3', 'DAXX', 'MAP2K1', 'CHUK', 'RRAS2', 'DUSP6', 'TGFBR1', 'MAPK8IP1', 'CDC25B', 'CACNB2', 'CACNB4', 'RASA1', 'RASA2', 'RAF1', 'TP53', 'PDGFB', 'CACNA1A', 'RAP1B', 'MAPK8', 'FLNB', 'CACNG2', 'PAK2', 'MAP2K5', 'MAP4K4', 'MAPK3', 'NTRK2', 'TGFB2', 'JUND', 'MAP3K1', 'NFATC3', 'MAPK14', 'MAPK13', 'TAOK1', 'NF1', 'TAB2', 'MAP3K13', 'LAMTOR3', 'MAP3K14']",0.6400978935667755,0,0,50
19,Sulindac Metabolic Pathway WP2542,0.0246060316594177,12.550447993767044,46.49644385350264,"['MSRA', 'CYP1B1', 'MSRB3']",0.6699631996991166,0,0,3
20,Type II diabetes mellitus WP1584,0.025460399916087263,3.5880320927122797,13.170341750834497,"['IKBKB', 'SURF1', 'MAPK8', 'INSR', 'CACNA1A', 'PHKA2']",0.6699631996991166,0,0,6
21,Netrin-UNC5B signaling pathway WP4747,0.026556300928552035,2.1858789135533874,7.931435923895534,"['PTPA', 'MAP2K1', 'ARHGEF12', 'PPP2R1B', 'NTN4', 'FYN', 'RAF1', 'MAPK14', 'TP53', 'RLF', 'PLEKHH1', 'MAPK3']",0.6699631996991166,0,0,12
22,Osteopontin Signaling WP1434,0.02839016954292696,4.185185185185185,14.906425704991658,"['IKBKB', 'MAP2K1', 'CHUK', 'MAP3K14', 'MAPK3']",0.6699631996991166,0,0,5
23,Circadian rhythm related genes WP3594,0.0308990929238047,1.4637520471904575,5.089507512889628,"['KDM5A', 'DDX5', 'PRKAA1', 'PHLPP1', 'AHCY', 'KMT2A', 'CIPC', 'BHLHE41', 'RBM4B', 'RORA', 'CCAR2', 'ARNTL2', 'NPAS2', 'PPP1CC', 'MAPK8', 'NAGLU', 'ADORA1', 'EP300', 'PRKG2', 'BTRC', 'CHRNB2', 'JUND', 'KCNH7', 'NONO', 'NTRK3', 'GFPT1', 'ARNT', 'NR1D1', 'BTBD9', 'SETX', 'PER2', 'STAR', 'PSPC1', 'BHLHE40', 'TOP1', 'TP53', 'LGR4', 'EZH2']",0.6699631996991166,0,0,38
24,Ebstein-Barr virus LMP1 signaling WP262,0.03149017932180956,2.93055013655872,10.134075495495804,"['IKBKB', 'MAP3K3', 'MAPK8', 'CHUK', 'MAP3K7', 'MAP3K14', 'PDLIM7']",0.6699631996991166,0,0,7
25,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.03325880976772013,2.0172511189327773,6.865584255279172,"['PRKAA1', 'PIK3R4', 'PLA2G6', 'GTPBP2', 'ATG13', 'RPTOR', 'DCAF17', 'DEPTOR', 'SCP2', 'AKT1S1', 'ATG7', 'ATG5', 'FTL']",0.6699631996991166,0,0,13
26,NRF2 pathway WP2884,0.03349696393367985,1.6234954260953298,5.513878283728995,"['GSTM4', 'GSTM3', 'TGFB2', 'SRXN1', 'SLC6A15', 'ABCC5', 'SLC2A13', 'GSTP1', 'PDGFB', 'SLC2A1', 'SLC39A11', 'KEAP1', 'MGST2', 'SLC2A6', 'SLC39A14', 'SLC6A6', 'DNAJB1', 'SLC5A8', 'FTH1', 'BLVRB', 'SLC39A7', 'FTL', 'NFE2L2', 'HBEGF']",0.6699631996991166,0,0,24
27,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.03379329768082166,1.4864944794952681,5.03548933110421,"['GRIA1', 'GABRB3', 'PRKAA1', 'SHC3', 'DOCK3', 'IKBKB', 'PPP2CA', 'RPS6KA3', 'MAPK8', 'RPS6KA5', 'SIRPA', 'FYN', 'MAP2K5', 'GRIA3', 'NCK1', 'MAPK3', 'NSF', 'NTRK2', 'MAP2K1', 'MAP3K1', 'CHUK', 'PDPK1', 'KIDINS220', 'SORT1', 'BAD', 'NTRK3', 'FRS2', 'MAPK14', 'TIAM1', 'DLG1', 'CDK5', 'RPS6KB1', 'RAF1', 'CDK5R1']",0.6699631996991166,0,0,34
28,Ectoderm Differentiation WP2858,0.03434735258979643,1.5401541304878474,5.192214325130782,"['STX16', 'CTNND2', 'ARHGDIG', 'PRKAG2', 'CDH8', 'HDAC6', 'ZBTB2', 'PHF8', 'CDH6', 'TRPM2', 'PLXNA2', 'DMD', 'FYN', 'CTNNA2', 'CLVS1', 'TTC14', 'BCAS3', 'KCNK10', 'SMURF1', 'GREB1', 'C1GALT1', 'SORCS1', 'SERPINB6', 'PAN2', 'PPFIBP2', 'KIFC3', 'TRIM33', 'ASTN1', 'BMPR1A']",0.6699631996991166,0,0,29
29,Sphingolipid Metabolism (general overview) WP4725,0.03551907274456011,2.5765928061010026,8.599856361659613,"['CERS4', 'UGCG', 'CERS6', 'SGMS1', 'DEGS1', 'SGMS2', 'KDSR', 'SGPP2']",0.6699631996991166,0,0,8
30,Resistin as a regulator of inflammation WP4481,0.038090707126011855,2.3554275673565015,7.69703071786186,"['IKBKB', 'CHUK', 'AKT2', 'ITPR1', 'MAPK14', 'PLCB1', 'PLCB2', 'PLCD4', 'MAPK3']",0.6945205599309495,0,0,9
31,Interleukin-11 Signaling Pathway WP2332,0.040566721960071224,2.0106333072713056,6.443692109016366,"['IKBKB', 'PTPA', 'MAP2K1', 'CHUK', 'RPS6KB1', 'BGLAP', 'PDPK1', 'FYN', 'RAF1', 'RUNX2', 'JAK1', 'MAPK3']",0.7027499116318172,0,0,12
32,Glycolysis in senescence WP5049,0.04393004500492267,3.487329434697856,10.898451284571125,"['PRKAA1', 'PKM', 'ENO1', 'TP53', 'HK1']",0.7027499116318172,0,0,5
33,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.04393004500492267,3.487329434697856,10.898451284571125,"['IKBKB', 'MAP3K1', 'CHUK', 'RAF1', 'MAP3K14']",0.7027499116318172,0,0,5
34,Pathways in clear cell renal cell carcinoma WP4018,0.044990516657336624,1.643829296424452,5.0980136364892,"['PDGFRA', 'SETD2', 'TGFB2', 'BHLHE41', 'SLC2A1', 'PDGFB', 'ARNT', 'ENO1', 'ENO2', 'SDSL', 'HK1', 'RPTOR', 'ACLY', 'LDHB', 'TOX2', 'DEPTOR', 'PKM', 'AKT1S1', 'EP300', 'CEP290']",0.7027499116318172,0,0,20
35,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.046642390622446434,2.3923274227723876,7.333070822538766,"['PPP2CA', 'MAP2K1', 'FGF9', 'MAPK14', 'RAF1', 'ATG5', 'MAPK3', 'MAPK13']",0.7027499116318172,0,0,8
36,Sphingolipid Metabolism (integrated pathway) WP4726,0.046642390622446434,2.3923274227723876,7.333070822538766,"['UGCG', 'CERS4', 'CERS6', 'SGMS1', 'DEGS1', 'SGMS2', 'KDSR', 'SGPP2']",0.7027499116318172,0,0,8
37,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.04846725003475807,1.8777797257022641,5.683789421420684,"['TGIF1', 'SMAD2', 'ZFYVE9', 'LTBP3', 'SMAD5', 'TGFBR1', 'RUNX2', 'ADAMTS10', 'ZEB2', 'EP300', 'ZNF423', 'JAK1', 'MAPK3']",0.7027499116318172,0,0,13
38,Glycolysis and Gluconeogenesis WP534,0.04946413152484849,2.09375,6.294875052430372,"['LDHB', 'PKM', 'PC', 'PGAM1', 'GOT2', 'SLC2A1', 'ENO1', 'ENO2', 'DLD', 'HK1']",0.7027499116318172,0,0,10
39,NLR Proteins WP288,0.05010465549111676,4.18394388152767,12.525227414984125,"['IKBKB', 'MAPK8', 'CHUK', 'MAP3K7']",0.7027499116318172,0,0,4
40,Glycosaminoglycan degradation WP4815,0.052454974584913154,2.790171606864275,8.224868153760083,"['NAGLU', 'IDUA', 'HEXB', 'IDS', 'ARSB', 'SGSH']",0.7032962408916382,0,0,6
41,Molybdenum cofactor (Moco) biosynthesis WP4507,0.052715074728623704,6.274639657187378,18.465347261420547,"['MARC2', 'SUOX', 'GPHN']",0.7032962408916382,0,0,3
42,T-cell receptor (TCR) signaling pathway WP69,0.05595744931865297,1.6397369497069647,4.727630068427262,"['MAP2K1', 'CHUK', 'PDPK1', 'ITPR1', 'CBLB', 'GAB2', 'BCL10', 'CBL', 'MAPK14', 'MALT1', 'IKBKB', 'MAPK8', 'FYN', 'RAF1', 'MAP3K7', 'MAP3K14', 'NCK1', 'MAPK3']",0.7287791613643613,0,0,18
43,Canonical and non-canonical TGF-B signaling WP3874,0.06363997784858931,2.9888610414926204,8.232857860025607,"['SMAD2', 'MAPK8', 'MAPK14', 'TGFBR1', 'BMPR1A']",0.7911606337085989,0,0,5
44,miRNAs involved in DNA damage response WP1545,0.06363997784858931,2.9888610414926204,8.232857860025607,"['RAD52', 'CDK6', 'ABL1', 'ATM', 'TP53']",0.7911606337085989,0,0,5
45,PKC-gamma calcium signaling pathway in ataxia WP4760,0.0739682683509935,2.2536390647978632,5.868744496658112,"['GRIA1', 'ITPR1', 'CACNA1A', 'CA8', 'PLCB1', 'PLCB2', 'GRIA3']",0.8070109123841962,0,0,7
46,Autophagy WP4923,0.0748534191519888,1.9829630695246512,5.140283446852548,"['RPTOR', 'PRKAA1', 'DEPTOR', 'AKT1S1', 'PIK3R4', 'PRKAG2', 'ATG7', 'ATG13', 'ATG5']",0.8070109123841962,0,0,9
47,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.0748534191519888,1.9829630695246512,5.140283446852548,"['HDAC4', 'PPP3CC', 'NFATC3', 'EP300', 'NELFB', 'HDAC8', 'SUPT5H', 'HDAC9', 'HDAC7']",0.8070109123841962,0,0,9
48,Sphingolipid pathway WP1422,0.07509110442467945,2.092896174863388,5.418619490589476,"['PPP2CA', 'UGCG', 'CERS4', 'CERS6', 'SGMS1', 'SGMS2', 'KDSR', 'SGPP2']",0.8070109123841962,0,0,8
49,Biotin Metabolism (including IEMs) WP5031,0.07671767357217221,3.346843335931411,8.593432504007234,"['BTD', 'PC', 'HLCS', 'MCCC1']",0.8070109123841962,0,0,4
50,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,0.07671767357217221,3.346843335931411,8.593432504007234,"['MAPK8', 'MAP2K1', 'MAFK', 'NFE2L2']",0.8070109123841962,0,0,4
51,Neuroinflammation WP4919,0.07671767357217221,3.346843335931411,8.593432504007234,"['MAPK8', 'CHUK', 'ASCC1', 'MAPK14']",0.8070109123841962,0,0,4
52,Thiamine metabolic pathways WP4297,0.07671767357217221,3.346843335931411,8.593432504007234,"['BCKDHA', 'SLC19A3', 'TKT', 'SLC19A2']",0.8070109123841962,0,0,4
53,Splicing factor NOVA regulated synaptic proteins WP4148,0.0824098968073847,1.7326575179962793,4.324799351450304,"['GABBR2', 'DAB1', 'EPB41L3', 'CASK', 'GRIK2', 'NCDN', 'ANK3', 'STX2', 'CAMK2G', 'GPHN', 'CLASP1', 'GABRG2']",0.8505323312007439,0,0,12
54,Amyotrophic lateral sclerosis (ALS) WP2447,0.08827001676055865,1.8201426630434783,4.41813201175245,"['GRIA1', 'DAXX', 'PPP3CC', 'BAD', 'DERL1', 'NEFL', 'NEFM', 'NOS1', 'MAPK14', 'TP53']",0.8677205264416081,0,0,10
55,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.09052482372179024,4.1827035449941565,10.047402562892925,"['HSD11B1', 'H6PD', 'STAR']",0.8677205264416081,0,0,3
56,Insulin signaling in adipocytes (diabetic condition) WP3635,0.09052482372179024,4.1827035449941565,10.047402562892925,"['RPS6KB1', 'INSR', 'AKT2']",0.8677205264416081,0,0,3
57,Insulin signaling in adipocytes (normal condition) WP3634,0.09052482372179024,4.1827035449941565,10.047402562892925,"['RPS6KB1', 'INSR', 'AKT2']",0.8677205264416081,0,0,3
58,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.09200692967753797,2.28244220677918,5.4456591914960715,"['SMAD2', 'MAPK8', 'MAPK14', 'TGFBR1', 'RUNX2', 'MAPK3']",0.8677205264416081,0,0,6
59,Effects of nitric oxide WP1995,0.09742915463730978,8.363707165109034,19.47597761098697,"['HBA1', 'NOS1']",0.8985517039540724,0,0,2
60,PDGF Pathway WP2526,0.10020412055063695,1.7055707524640702,3.923743917578484,"['TIAM1', 'MAPK8', 'MAP2K1', 'MAP3K1', 'CHUK', 'RASA1', 'PDGFB', 'ARFIP2', 'RAF1', 'JAK1', 'MAPK3']",0.8985517039540724,0,0,11
61,TGF-beta Receptor Signaling WP560,0.10020412055063695,1.7055707524640702,3.923743917578484,"['TGIF1', 'SMAD2', 'ZEB2', 'ZFYVE9', 'EP300', 'ZNF423', 'SMAD5', 'TGFBR1', 'RUNX2', 'JAK1', 'MAPK3']",0.8985517039540724,0,0,11
62,Phosphoinositides metabolism WP4971,0.10438141594474598,1.744140625,3.9412408973064963,"['PIP4P1', 'PIK3R4', 'PIP4K2A', 'PIP4K2B', 'PIP4K2C', 'PIK3C2A', 'PLCB1', 'PLCB2', 'PLCD4', 'PIK3C2B']",0.9209134600286459,0,0,10
63,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.10839116779206813,1.793774753165616,3.985783055765746,"['MAP2K1', 'STAR', 'AKT2', 'ARRB1', 'AMH', 'RAF1', 'PLCB1', 'PLCB2', 'MAPK3']",0.922815010520524,0,0,9
64,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.1089360313442862,2.7887763055339048,6.182701556601634,"['GRM3', 'GABBR2', 'GRM4', 'GRM7']",0.922815010520524,0,0,4
65,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.11083529070072393,1.6205705061918334,3.5647852247514438,"['RPTOR', 'MAP2K3', 'MAPK8', 'MAP2K1', 'RPS6KA5', 'RPS6KB1', 'AKT2', 'PRKACA', 'MAPK14', 'MAP2K5', 'MAPK3', 'EIF4G1']",0.922815010520524,0,0,12
66,Lipid Metabolism Pathway WP3965,0.11202262815943363,1.8600052042674993,4.071652559602773,"['BCKDHA', 'ACLY', 'PRKAA1', 'PRKAR2A', 'AKT2', 'PRKAG2', 'ABHD5', 'PRKACA']",0.922815010520524,0,0,8
67,miRNAs involvement in the immune response in sepsis WP4329,0.11642898412084668,2.09204368174727,4.498885063724033,"['IKBKB', 'MAPK8', 'CHUK', 'TAB2', 'MAPK14', 'MAP3K7']",0.922815010520524,0,0,6
68,Thermogenesis WP4321,0.11732000370706237,1.3764653093275,2.949558692600378,"['MAP2K3', 'SMARCC1', 'PRKAA1', 'SMARCD2', 'SMARCD3', 'ACSL5', 'PRKAG2', 'FRS2', 'CPT1C', 'MAPK14', 'SMARCA2', 'ARID1B', 'ADCY5', 'MAPK13', 'RPTOR', 'RPS6KA3', 'RPS6KA6', 'RPS6KB1', 'AKT1S1', 'GNAS', 'PRKG2', 'SLC25A20', 'PRKACA']",0.922815010520524,0,0,23
69,IL-1 signaling pathway WP195,0.12033643272730851,1.555003072797363,3.2926627978161704,"['MAP2K3', 'MAP3K3', 'MAP2K1', 'MAP3K1', 'CHUK', 'MAPK14', 'IKBKB', 'MAPK8', 'IRAK2', 'TAB2', 'MAP3K7', 'MAP3K14', 'MAPK3']",0.922815010520524,0,0,13
70,miRNA regulation of DNA damage response WP1530,0.12189385691536068,1.4953871959742802,3.147198828588955,"['RPA2', 'RAD52', 'PIDD1', 'CCNB1', 'CDK6', 'RRM2B', 'CDK5', 'CCNG1', 'TLK2', 'ABL1', 'TLK1', 'ATM', 'TP53', 'RAD9A', 'ATR']",0.922815010520524,0,0,15
71,IL-3 signaling pathway WP286,0.1220677469100597,1.67421875,3.5211818601058016,"['MAP2K1', 'MAPK8', 'BAD', 'FYN', 'GAB2', 'PRKACA', 'RAF1', 'CBL', 'JAK1', 'MAPK3']",0.922815010520524,0,0,10
72,RANKL/RANK signaling pathway WP2018,0.12694072241221713,1.5697810789679436,3.240083174325253,"['IKBKB', 'MAP2K1', 'MAPK8', 'CHUK', 'AKT2', 'TAB2', 'GAB2', 'CBL', 'MAPK14', 'MAP3K7', 'PAPSS2', 'MAPK3']",0.922815010520524,0,0,12
73,Synaptic Vesicle Pathway WP2267,0.12694072241221713,1.5697810789679436,3.240083174325253,"['UNC13B', 'NSF', 'DNM3', 'RIMS1', 'STX1B', 'SYT1', 'CLTC', 'CACNA1A', 'SLC17A7', 'STX2', 'SYN2', 'DNM2']",0.922815010520524,0,0,12
74,Pathways affected in adenoid cystic carcinoma WP3651,0.1288607677666838,1.5028891296496931,3.0794540581735412,"['SETD2', 'CNTN6', 'MGA', 'SMARCA2', 'KANSL1', 'NSD1', 'EP300', 'TLK1', 'ATM', 'MAML3', 'RAF1', 'TP53', 'CMTR2', 'KDM6A']",0.922815010520524,0,0,14
75,Regulatory circuits of the STAT3 signaling pathway WP4538,0.1288607677666838,1.5028891296496931,3.0794540581735412,"['PDGFRA', 'IL10RB', 'MAPKAP1', 'SETD7', 'IFNLR1', 'MAPK14', 'MAPK13', 'RPTOR', 'PTPRD', 'MAPK8', 'DEPTOR', 'AKT1S1', 'JAK1', 'MAPK3']",0.922815010520524,0,0,14
76,IL-10 Anti-inflammatory Signaling Pathway  WP4495,0.13629641698123474,3.136735488897546,6.251273017056797,"['IL10RB', 'BLVRB', 'JAK1']",0.922815010520524,0,0,3
77,Osteoblast Signaling WP322,0.13629641698123474,3.136735488897546,6.251273017056797,"['PDGFRA', 'BGLAP', 'PDGFB']",0.922815010520524,0,0,3
78,Type III interferon signaling WP2113,0.13629641698123474,3.136735488897546,6.251273017056797,"['IL10RB', 'IFNLR1', 'JAK1']",0.922815010520524,0,0,3
79,TGF-beta Signaling Pathway WP366,0.1396003168690757,1.312239524134273,2.5837626425630105,"['ROCK1', 'ZFYVE9', 'MAPK8', 'PRKAR2A', 'EP300', 'BTRC', 'MAP3K7', 'PAK2', 'NUP214', 'MAP2K3', 'SMAD2', 'TGIF1', 'MAP2K1', 'JUND', 'SMURF1', 'LIMK2', 'MAPK14', 'PIAS2', 'RUNX2', 'TGFBR1', 'PJA1', 'ZEB2', 'ZFYVE16', 'RAF1', 'DCP1A', 'TP53']",0.922815010520524,0,0,26
80,Pathways Regulating Hippo Signaling WP4540,0.14137052670270278,1.39576802507837,2.7306400680174234,"['SMAD2', 'PDGFRA', 'NTRK2', 'PRKAA1', 'FLT3', 'INSR', 'PRKAG2', 'CDH8', 'CDH6', 'LATS1', 'CDH4', 'CDH20', 'PRKAR2A', 'GNAS', 'CDH12', 'PRKACA', 'PLCB1', 'PLCB2']",0.922815010520524,0,0,18
81,Angiogenesis WP1539,0.14372127020908243,1.9309372374894995,3.745785521652562,"['PDGFRA', 'PDGFB', 'TIMP2', 'ARNT', 'MAPK14', 'FGF2']",0.922815010520524,0,0,6
82,Computational Model of Aerobic Glycolysis WP4629,0.14608232491466216,2.390156998107115,4.597670022310055,"['PKM', 'SLC2A1', 'ENO1', 'HK1']",0.922815010520524,0,0,4
83,RAS and bradykinin pathways in COVID-19 WP4969,0.14608232491466216,2.390156998107115,4.597670022310055,"['ROCK1', 'SERPING1', 'NOS1', 'AGT']",0.922815010520524,0,0,4
84,"4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression WP3879",0.1467541792510627,2.091617933723197,4.013807163607221,"['MAP2K3', 'PRKAA1', 'MAP2K1', 'RAF1', 'MAPK3']",0.922815010520524,0,0,5
85,Kynurenine Pathway and links to Cellular Senescence WP5044,0.1467541792510627,2.091617933723197,4.013807163607221,"['KLF5', 'TDO2', 'EIF2AK4', 'NOS1', 'TP53']",0.922815010520524,0,0,5
86,G13 Signaling Pathway WP524,0.14901651702789664,1.637488752695109,3.1172842709065405,"['ROCK1', 'RPS6KB1', 'CFL2', 'TNK2', 'ARHGDIG', 'PIP4K2A', 'ARHGEF1', 'IQGAP1', 'MAP3K4']",0.922815010520524,0,0,9
87,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.14901651702789664,1.637488752695109,3.1172842709065405,"['IKBKB', 'MAPK8', 'CHUK', 'AKT2', 'MAPK14', 'RAF1', 'MAP3K7', 'MAP3K14', 'MAPK3']",0.922815010520524,0,0,9
88,EGF/EGFR signaling pathway WP437,0.15140902826735209,1.2496679395650008,2.3590860310103174,"['ROCK1', 'SH3KBP1', 'INPPL1', 'CBLB', 'ASAP1', 'IQGAP1', 'CBL', 'PIK3C2B', 'RPS6KA3', 'MAPK8', 'RPS6KA5', 'ABL1', 'MAP3K4', 'MAP2K5', 'NCK1', 'JAK1', 'MAP3K3', 'MAP2K1', 'JUND', 'MAP3K1', 'PDPK1', 'TNK2', 'NCOA3', 'LIMK2', 'EPS15L1', 'GAB2', 'MAPK14', 'EPN1', 'RPS6KB1', 'RASA1', 'ARHGEF1', 'RAF1', 'STAM2', 'ARF6']",0.922815010520524,0,0,34
89,ATM Signaling Network in Development and Disease  WP3878,0.15281013351043787,1.5345838218053927,2.882806381164158,"['HDAC4', 'PTPA', 'RNF168', 'PRKAA1', 'ATMIN', 'CDK5', 'ATM', 'CEP63', 'RNF40', 'CDK5R1', 'ATR']",0.922815010520524,0,0,11
90,TNF-alpha signaling pathway WP231,0.16078162022033463,1.3483512613863622,2.4643926985567934,"['MAP2K3', 'MAP3K3', 'MAP3K1', 'CHUK', 'BAD', 'KSR2', 'TANK', 'IKBKB', 'PPP2CA', 'MAPK8', 'PSMD2', 'TAB2', 'BTRC', 'RAF1', 'RFFL', 'MAP3K7', 'MAP3K14', 'NSMAF', 'MAPK3']",0.922815010520524,0,0,19
91,DNA damage response WP707,0.16143782876359006,1.4293102790182832,2.6065404960217284,"['RPA2', 'RAD52', 'PIDD1', 'CCNB1', 'CDK6', 'RRM2B', 'CDK5', 'TLK2', 'ABL1', 'TLK1', 'ATM', 'TP53', 'RAD9A', 'ATR']",0.922815010520524,0,0,14
92,Joubert Syndrome WP4656,0.16492220604925065,1.3686462382114557,2.466685651125652,"['CEP164', 'CEP120', 'MYO5A', 'CPLANE1', 'RPGRIP1L', 'PCM1', 'NIN', 'ARL13B', 'TMEM237', 'DVL1', 'MYO6', 'ANKS6', 'ATM', 'ZNF423', 'BBS5', 'CEP290', 'PIBF1']",0.922815010520524,0,0,17
93,Aryl Hydrocarbon Receptor Pathway WP2873,0.16535077133840043,1.7227284202795436,3.100370520709266,"['JUND', 'AIP', 'EP300', 'CYP1B1', 'ARNT', 'POLK', 'NFE2L2']",0.922815010520524,0,0,7
94,Cell migration and invasion through p75NTR WP4561,0.16535077133840043,1.7227284202795436,3.100370520709266,"['EFNB2', 'NTRK2', 'TIAM1', 'EFNA3', 'ADAMTS13', 'KIDINS220', 'AKT2']",0.922815010520524,0,0,7
95,Neovascularisation processes WP4331,0.16535077133840043,1.7227284202795436,3.100370520709266,"['SMAD2', 'MAPK8', 'TGFB2', 'PDGFB', 'SMAD5', 'TGFBR1', 'MAPK3']",0.922815010520524,0,0,7
96,Fragile X Syndrome  WP4549,0.16571497354052772,1.2706261294498669,2.2839326703690803,"['CYFIP2', 'GRIA1', 'ABCD3', 'CLTC', 'ITPR1', 'GPHN', 'RPTOR', 'DEPTOR', 'FYN', 'PRKACA', 'SH3GL1', 'EPHA4', 'GABRA1', 'NTRK2', 'MAP2K1', 'GABRG2', 'DNM2', 'ALDH3A2', 'RPS6KB1', 'MAP1B', 'TBC1D7', 'AKT1S1', 'NF1', 'RAF1', 'PLCB1', 'EIF4G1', 'SHANK1']",0.922815010520524,0,0,27
97,Role of Osx and miRNAs in tooth development WP3971,0.17025231394327142,4.181464174454828,7.40317252650024,"['NOTCH2', 'RUNX2']",0.922815010520524,0,0,2
98,Ferroptosis WP4313,0.17179645843295221,1.569113627489262,2.7639071717453114,"['FTH1', 'VDAC3', 'ACSL5', 'SAT2', 'ATG7', 'SLC39A14', 'TP53', 'ATG5', 'FTL']",0.922815010520524,0,0,9
99,Type 2 papillary renal cell carcinoma WP4241,0.17179645843295221,1.569113627489262,2.7639071717453114,"['SETD2', 'TGFB2', 'EGLN3', 'EGLN2', 'CADM2', 'PDGFB', 'SLC2A1', 'EP300', 'ARNT']",0.922815010520524,0,0,9
100,VEGFA-VEGFR2 Signaling Pathway WP3888,0.17209655327452375,1.140002013411558,2.006061090901661,"['ARF4', 'KCNC3', 'FAF1', 'CLTC', 'NRARP', 'SHB', 'HERPUD1', 'RPS6KA5', 'BSG', 'ELOA', 'SH3BGRL3', 'CHAC1', 'RPS11', 'IER5', 'NCK1', 'MAP2K3', 'ACOT9', 'MAP2K1', 'PDPK1', 'TRPC1', 'ARNT', 'ADAM10', 'FRS2', 'SND1', 'EPN1', 'ARMCX1', 'EWSR1', 'RAB37', 'AKT1S1', 'ADAM9', 'MYH9', 'TKT', 'RAF1', 'ATF6', 'FJX1', 'VCL', 'ARF6', 'HBEGF', 'HDAC4', 'PRKAA1', 'ROCK1', 'MAPKAP1', 'IQGAP1', 'CBL', 'HDAC9', 'APOLD1', 'HDAC7', 'RAP1B', 'PPP2CA', 'MAPK8', 'DNAJB4', 'MYO6', 'ABL1', 'DNAJB9', 'FLNB', 'FYN', 'PAK2', 'BRD4', 'MAPK3', 'PTPN1', 'RBM39', 'RAB4A', 'PRRC2C', 'TRIP4', 'MICAL2', 'PDE4DIP', 'SOD2', 'MAPK14', 'SMARCA2', 'QKI', 'TPCN2', 'CYP2C8', 'RPS6KB1', 'SPIRE1', 'PTPN9', 'COPG1', 'FARSB', 'EIF4G1']",0.922815010520524,0,0,78
101,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.17361542019896475,1.7928459995542678,3.139116748493663,"['RPS6KB1', 'PRKACA', 'MAPK14', 'SGK1', 'RAF1', 'MAPK3']",0.922815010520524,0,0,6
102,Urea cycle and associated pathways WP4595,0.17361542019896475,1.7928459995542678,3.139116748493663,"['SLC25A15', 'LDHB', 'OAT', 'GOT2', 'NOS1', 'SLC25A12']",0.922815010520524,0,0,6
103,Hippo-Merlin Signaling Dysregulation WP4541,0.17545294532748534,1.3257546060368484,2.307322621076273,"['PDGFRA', 'NTRK2', 'FLT3', 'INSR', 'CDH8', 'CDH6', 'DCAF1', 'LATS1', 'CUL4A', 'PPP1CC', 'CDH4', 'LIN28B', 'CDH20', 'PRKAR2A', 'CDH12', 'ITGB8', 'PRKACA', 'PAK2', 'VGLL4']",0.922815010520524,0,0,19
104,Pancreatic adenocarcinoma pathway WP4263,0.17545294532748534,1.3257546060368484,2.307322621076273,"['SMAD2', 'MAP2K1', 'TGFB2', 'CHUK', 'BAD', 'TGFBR1', 'DUSP6', 'IKBKB', 'TIAM1', 'MAPK8', 'CDK6', 'RPS6KB1', 'AKT2', 'POLK', 'RAF1', 'TP53', 'PAK2', 'JAK1', 'MAPK3']",0.922815010520524,0,0,19
105,Kit receptor signaling pathway WP304,0.18243447754702177,1.4348263152016083,2.441162122407946,"['RPS6KA3', 'MAP2K1', 'MAPK8', 'RPS6KB1', 'BAD', 'EP300', 'FYN', 'GAB2', 'RAF1', 'CBL', 'MAPK14', 'MAPK3']",0.9414307473417066,0,0,12
106,Rett syndrome causing genes WP4312,0.18243447754702177,1.4348263152016083,2.441162122407946,"['KDM5B', 'SRRM3', 'GABBR2', 'XAB2', 'EIF2B2', 'TAF1B', 'FOXG1', 'IMPDH2', 'HTT', 'TCF4', 'HDAC8', 'SMARCA2']",0.9414307473417066,0,0,12
107,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.18730350785696537,2.0911925175370225,3.5027996236414154,"['SMAD2', 'CDH6', 'RUNX2', 'MAPK3']",0.9575235401659817,0,0,4
108,3q29 copy number variation syndrome WP4906,0.19064630773528282,1.3949941337504888,2.31197310427657,"['DYNC2H1', 'GRIA1', 'PCYT1A', 'MYCBP2', 'ADAM10', 'MAD2L1BP', 'ZNF76', 'RNF168', 'DLG1', 'BRINP1', 'WDR60', 'FGFR1OP', 'PAK2']",0.9655882438074047,0,0,13
109,NO/cGMP/PKG mediated Neuroprotection WP4008,0.1960658761455609,1.506208512299883,2.454072417641496,"['GUCY1A2', 'CAMK2D', 'BAD', 'AKAP9', 'NEFL', 'PRKG2', 'NOS1', 'CAMK2G', 'PPID']",0.9839269197396497,0,0,9
110,Cardiac Progenitor Differentiation WP2406,0.20578444093416054,1.673166926677067,2.6451531992670354,"['PDGFRA', 'LIN28B', 'SIRPA', 'THY1', 'MAPK14', 'FGF2']",0.9999960853589026,0,0,6
111,MAPK Cascade WP422,0.20924911936577775,1.5212547015825704,2.3795919043633456,"['MAP2K3', 'MAP3K3', 'MAP2K1', 'MAP3K1', 'MAPK14', 'RAF1', 'LAMTOR3', 'MAPK3']",0.9999960853589026,0,0,8
112,Interferon type I signaling pathways WP585,0.2167972333904735,1.3946854239937476,2.1321849934797434,"['RPTOR', 'MAP2K3', 'RPS6KA5', 'MAP3K1', 'RPS6KB1', 'MAPKAP1', 'FYN', 'GAB2', 'CBL', 'MAPK14', 'JAK1']",0.9999960853589026,0,0,11
113,ErbB signaling pathway WP673,0.22334174238251883,1.2622687648167852,1.8922067733267989,"['MAP2K1', 'CAMK2D', 'SHC3', 'PDPK1', 'BAD', 'CBLB', 'NRG2', 'CBL', 'MAPK8', 'RPS6KB1', 'AKT2', 'ABL1', 'RAF1', 'TP53', 'PAK2', 'CAMK2G', 'NCK1', 'HBEGF', 'MAPK3']",0.9999960853589026,0,0,19
114,Alzheimer's disease WP2059,0.22825182039318917,1.2876332751039095,1.9022280851147573,"['LRP1', 'BAD', 'ITPR1', 'ADAM10', 'PSEN1', 'VMP1', 'PPP3CC', 'CDK5', 'NOS1', 'APBB1', 'PLCB1', 'ATF6', 'PLCB2', 'TP53', 'MAPK3', 'CDK5R1']",0.9999960853589026,0,0,16
115,Nicotine Activity on Dopaminergic Neurons WP1602,0.23165963371909257,1.8586645882047286,2.71827108874119,"['CHRNB2', 'CDK5', 'PRKACA', 'KCNK3']",0.9999960853589026,0,0,4
116,Prader-Willi and Angelman Syndrome WP3998,0.23182937547636906,1.39453125,2.0384611146397376,"['GABRB3', 'PCSK1', 'PCM1', 'HERC2', 'CDK6', 'NIPA1', 'MDM4', 'GABRG3', 'TP53', 'GABRG2']",0.9999960853589026,0,0,10
117,IL-2 signaling pathway WP49,0.2375622604844645,1.454977429318128,2.0912762199435178,"['MAP2K1', 'RPS6KB1', 'FYN', 'GAB2', 'CBL', 'RAF1', 'JAK1', 'MAPK3']",0.9999960853589026,0,0,8
118,Estrogen signaling pathway WP712,0.2398599392902375,1.5684477379095163,2.239273011524347,"['IKBKB', 'MAP2K1', 'CHUK', 'GNAS', 'MAPK14', 'PRKACA']",0.9999960853589026,0,0,6
119,MTHFR deficiency WP4288,0.2398599392902375,1.5684477379095163,2.239273011524347,"['PCYT1A', 'SGMS1', 'NDUFAF7', 'MARS', 'DNMT3A', 'EHMT1']",0.9999960853589026,0,0,6
120,Physiological and pathological hypertrophy of the heart WP1528,0.2398599392902375,1.5684477379095163,2.239273011524347,"['MAP2K3', 'CAMK2D', 'MAPK8', 'MYEF2', 'MAPK14', 'AGT']",0.9999960853589026,0,0,6
121,Bone morphogenic protein (BMP) signaling and regulation WP1425,0.24365840006566625,2.090767432800935,2.9521385976923566,"['SMURF1', 'RUNX2', 'BMPR1A']",0.9999960853589026,0,0,3
122,Cytosine methylation WP3585,0.24365840006566625,2.090767432800935,2.9521385976923566,"['TET3', 'TET2', 'TET1']",0.9999960853589026,0,0,3
123,Matrix Metalloproteinases WP129,0.24365840006566625,2.090767432800935,2.9521385976923566,"['BSG', 'TIMP2', 'TCF20']",0.9999960853589026,0,0,3
124,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.24861048098192187,2.7873831775700935,3.87966928350258,"['CYP2C8', 'GSTP1']",0.9999960853589026,0,0,2
125,Metastatic brain tumor WP2249,0.24861048098192187,2.7873831775700935,3.87966928350258,"['CDK6', 'TP53']",0.9999960853589026,0,0,2
126,mir-124 predicted interactions with cell cycle and differentiation  WP3595,0.24861048098192187,2.7873831775700935,3.87966928350258,"['PRKAA1', 'SIX4']",0.9999960853589026,0,0,2
127,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.24861048098192187,2.7873831775700935,3.87966928350258,"['NKRF', 'FYN']",0.9999960853589026,0,0,2
128,Somatic sex determination WP4814,0.24861048098192187,2.7873831775700935,3.87966928350258,"['FGF9', 'AMH']",0.9999960853589026,0,0,2
129,TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer WP2868,0.24861048098192187,2.7873831775700935,3.87966928350258,"['JAK1', 'MAPK3']",0.9999960853589026,0,0,2
130,Regulation of toll-like receptor signaling pathway WP1449,0.2549694789813746,1.234788529729174,1.6874761199120265,"['MAP2K3', 'USP7', 'MAP2K1', 'CHUK', 'MAPK14', 'RNF41', 'MAPK13', 'IKBKB', 'MAPK8', 'IRAK2', 'AKT2', 'SARM1', 'TAB2', 'TMED7', 'ZMYND11', 'MAP3K7', 'CTNNAL1', 'MAPK3']",0.9999960853589026,0,0,18
131,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.2553288955438519,1.4639094810768631,1.998533290946774,"['IKBKB', 'MAPK8', 'CHUK', 'DDX58', 'MAPK14', 'MAP3K7', 'JAK1']",0.9999960853589026,0,0,7
132,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.25785953374484044,1.6084870295396612,2.1800472693130337,"['UGCG', 'B3GALT1', 'SGMS2', 'KDSR', 'SGPP2']",0.9999960853589026,0,0,5
133,Monoamine Transport WP727,0.25785953374484044,1.6084870295396612,2.1800472693130337,"['UNC13B', 'TDO2', 'NOS1', 'MAPK14', 'AGT']",0.9999960853589026,0,0,5
134,Vitamin D in inflammatory diseases WP4482,0.25785953374484044,1.6084870295396612,2.1800472693130337,"['MAP2K3', 'IKBKB', 'MAP3K1', 'CHUK', 'MAPK14']",0.9999960853589026,0,0,5
135,Nuclear Receptors Meta-Pathway WP2882,0.2604121446819721,1.1368758166853898,1.5296547369675477,"['SRXN1', 'GSTP1', 'ABHD2', 'AMIGO2', 'PDGFB', 'SLC2A1', 'KEAP1', 'MGST2', 'SLC2A6', 'PTPA', 'DNAJB1', 'RGS2', 'SCP2', 'FTH1', 'CYP1B1', 'EP300', 'STOM', 'SLC39A7', 'POLK', 'SLC19A2', 'GSTM4', 'GSTM3', 'TGFB2', 'JUND', 'NCOA6', 'SLC6A15', 'NCOA3', 'SLC2A13', 'ABCC5', 'SLC39A11', 'AIP', 'ARNT', 'SLC39A14', 'SLC6A6', 'SLC5A8', 'NAV3', 'BHLHE40', 'BLVRB', 'HBEGF', 'FTL', 'NFE2L2']",0.9999960853589026,0,0,41
136,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.2670775067891401,1.394223263075722,1.8406763824682477,"['RPTOR', 'SMAD2', 'DEPTOR', 'EIF2B2', 'RPS6KB1', 'MAPKAP1', 'JKAMP', 'AKT1S1']",0.9999960853589026,0,0,8
137,Integrin-mediated Cell Adhesion WP185,0.27360219614665415,1.2147588229345738,1.5744246959062178,"['MAP2K3', 'GIT2', 'MAP2K1', 'SHC3', 'ROCK1', 'PDPK1', 'SORBS1', 'RAP1B', 'AKT2', 'ZYX', 'CAPN3', 'ITGB8', 'FYN', 'RAF1', 'ARHGEF7', 'PAK2', 'VCL', 'MAP2K5']",0.9999960853589026,0,0,18
138,Ethanol effects on histone modifications WP3996,0.275448728285622,1.476048453702854,1.9031486413407848,"['HDAC4', 'AHCY', 'HDAC8', 'HDAC9', 'HDAC6', 'HDAC7']",0.9999960853589026,0,0,6
139,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.275448728285622,1.476048453702854,1.9031486413407848,"['RAB4A', 'NEFL', 'MFN2', 'KIF1B', 'RABAC1', 'DNM2']",0.9999960853589026,0,0,6
140,Sleep regulation WP3591,0.275448728285622,1.476048453702854,1.9031486413407848,"['CHRNB2', 'AHCY', 'STAR', 'ADORA1', 'BTBD9', 'NPAS2']",0.9999960853589026,0,0,6
141,Common Pathways Underlying Drug Addiction WP2636,0.27628687428112425,1.3444525018129079,1.729390164020454,"['GRIA1', 'RAP1B', 'PPP1CC', 'MAP2K1', 'GNAS', 'PRKACA', 'RAF1', 'GRIA3', 'MAPK3']",0.9999960853589026,0,0,9
142,DNA damage response (only ATM dependent) WP710,0.27630599179688686,1.204554363707637,1.5493536674882133,"['MAP3K1', 'BAD', 'INSR', 'PIK3R4', 'PPP2R5C', 'PIK3C2A', 'SOD2', 'PIK3C2B', 'MAPK8', 'SCP2', 'AKT2', 'CCNG2', 'DVL1', 'ABL1', 'ATM', 'MAP3K7', 'TP53', 'WNT2', 'MAP3K4']",0.9999960853589026,0,0,19
143,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.2781950434867027,1.6726422447388931,2.1400333773777875,"['MAP3K1', 'ROCK1', 'FGF9', 'MAP3K4']",0.9999960853589026,0,0,4
144,Ciliopathies WP4803,0.28118690093831883,1.1385173501577288,1.4444776104633181,"['IFT172', 'ANKS3', 'CEP120', 'CEP164', 'PIK3R4', 'LRRC6', 'FLCN', 'ARL13B', 'TBC1D32', 'KIAA0753', 'POC1B', 'ZNF423', 'PIBF1', 'BBS5', 'CEP290', 'CEP78', 'DYNC2H1', 'IQCB1', 'CFAP52', 'DNAAF5', 'IFT80', 'CPLANE1', 'RPGRIP1L', 'BBS10', 'ARL2BP', 'WDR60', 'TMEM237', 'GPR161', 'NME9', 'ALMS1', 'ANKS6', 'WDPCP', 'CCDC65', 'SDCCAG8']",0.9999960853589026,0,0,34
145,Endoderm differentiation WP2853,0.2827595208922839,1.1802318560560319,1.4908198915980282,"['MAP2K3', 'SMAD2', 'CTBP2', 'ATP8B2', 'SFMBT1', 'TET1', 'CDYL', 'FOXN3', 'ELP4', 'TRERF1', 'CDC73', 'EXT1', 'MAD2L2', 'TNRC6C', 'EPB41L5', 'UBR5', 'CEP250', 'DIP2A', 'TCF4', 'NAA15', 'EZH2', 'BMPR1A']",0.9999960853589026,0,0,22
146,Leptin signaling pathway WP2034,0.28405755156446116,1.2304593070104755,1.548629524335789,"['PTPN1', 'MAP2K1', 'PRKAA1', 'CHUK', 'ROCK1', 'BAD', 'MAPK14', 'IKBKB', 'MAPK8', 'RPS6KB1', 'CFL2', 'FYN', 'RAF1', 'JAK1', 'MAPK3']",0.9999960853589026,0,0,15
147,PDGFR-beta pathway WP3972,0.2880806936486972,1.3940694498634414,1.7349398559969271,"['MAPK8', 'MAP2K1', 'MAP3K1', 'RASA1', 'RAF1', 'JAK1', 'MAPK3']",0.9999960853589026,0,0,7
148,Tumor suppressor activity of SMARCB1 WP4204,0.2880806936486972,1.3940694498634414,1.7349398559969271,"['GLI4', 'SMARCD2', 'SMARCC1', 'SMARCD3', 'CDK6', 'ARID1B', 'EZH2']",0.9999960853589026,0,0,7
149,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.2897168616028666,1.2781034258173767,1.5833799273072697,"['IKBKB', 'MAPK8', 'TKFC', 'MAP3K1', 'CHUK', 'DDX58', 'MAPK14', 'MAP3K7', 'TANK', 'ATG5', 'MAPK13']",0.9999960853589026,0,0,11
150,Glioblastoma signaling pathways WP2261,0.2901994627160894,1.2054744501317824,1.4913970653374058,"['MAP2K3', 'PDGFRA', 'MAP2K1', 'PDPK1', 'PIK3C2A', 'CBL', 'PIK3C2B', 'CDK6', 'AKT2', 'NF1', 'EP300', 'ATM', 'MDM4', 'RAF1', 'TP53', 'MAP2K5', 'MAPK3']",0.9999960853589026,0,0,17
151,p38 MAPK Signaling Pathway WP400,0.29756743896911203,1.3383294301327089,1.6222083662784403,"['TGFB2', 'DAXX', 'RPS6KA5', 'MAP3K1', 'MAP3K9', 'MAPK14', 'MAP3K7', 'TGFBR1']",0.9999960853589026,0,0,8
152,Gastric Cancer Network 1 WP2361,0.29862319504381807,1.4934558618769145,1.804950009570968,"['CCNA1', 'INO80D', 'CASTOR3', 'CEP192', 'GATD3B']",0.9999960853589026,0,0,5
153,Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex WP3657,0.29862319504381807,1.4934558618769145,1.804950009570968,"['FLT3', 'DNMT3A', 'EP300', 'ATM', 'ETV6']",0.9999960853589026,0,0,5
154,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.29862319504381807,1.4934558618769145,1.804950009570968,"['PRKAA1', 'SLC2A1', 'KEAP1', 'TP53', 'NFE2L2']",0.9999960853589026,0,0,5
155,IL-7 signaling pathway WP205,0.29862319504381807,1.4934558618769145,1.804950009570968,"['MAP2K1', 'BAD', 'FYN', 'JAK1', 'MAPK3']",0.9999960853589026,0,0,5
156,TLR4 Signaling and Tolerance WP3851,0.29862319504381807,1.4934558618769145,1.804950009570968,"['IKBKB', 'TRAM1', 'CHUK', 'TAB2', 'MAP3K7']",0.9999960853589026,0,0,5
157,AMP-activated protein kinase (AMPK) signaling WP1403,0.2989157307257561,1.2358943364027446,1.4924580691058518,"['PRKAA1', 'INSR', 'PRKAG2', 'CPT1C', 'RPTOR', 'GYS1', 'CCNA1', 'CCNB1', 'EEF2K', 'RPS6KB1', 'AKT2', 'PLCB1', 'TP53']",0.9999960853589026,0,0,13
158,Alanine and aspartate metabolism WP106,0.3013965526785649,1.7919194167733319,2.149099901792069,"['DARS', 'PC', 'GOT2']",0.9999960853589026,0,0,3
159,Dopamine metabolism WP2436,0.3013965526785649,1.7919194167733319,2.149099901792069,"['PPP2CA', 'MAOB', 'PRKACA']",0.9999960853589026,0,0,3
160,Aryl Hydrocarbon Receptor Netpath WP2586,0.3049201076381725,1.297970889604007,1.5416071369802145,"['MAP2K1', 'PSRC1', 'AIP', 'NF1', 'EP300', 'CYP1B1', 'ARNT', 'RAF1', 'NFE2L2']",0.9999960853589026,0,0,9
161,Fluoropyrimidine Activity WP1601,0.31214804236637494,1.3939157566302651,1.6229050435927628,"['SMUG1', 'UCK1', 'DPYS', 'ABCC5', 'XRCC3', 'TP53']",0.9999960853589026,0,0,6
162,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.3217211070532928,1.3305785123966942,1.508969487445534,"['MAPK8', 'MAP2K1', 'FYN', 'GAB2', 'MAPK14', 'JAK1', 'MAPK3']",0.9999960853589026,0,0,7
163,Ras signaling WP4223,0.322085773093345,1.1207817772778403,1.269775584695375,"['RAB5B', 'SHC3', 'FLT3', 'RASAL1', 'PLA2G6', 'RAP1B', 'IKBKB', 'MAPK8', 'RASSF5', 'AKT2', 'ABL1', 'PRKACA', 'PAK2', 'MAPK3', 'PDGFRA', 'NTRK2', 'MAP2K1', 'PLA2G12A', 'CHUK', 'BAD', 'INSR', 'RRAS2', 'KSR2', 'GAB2', 'TIAM1', 'RASA1', 'RASA2', 'NF1', 'RAF1', 'ARF6']",0.9999960853589026,0,0,30
164,ERK Pathway in Huntington's Disease WP3853,0.32599171386704523,1.5204421455395734,1.7042382331551444,"['NTRK2', 'RPS6KA5', 'HTT', 'RAF1']",0.9999960853589026,0,0,4
165,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.32599171386704523,1.5204421455395734,1.7042382331551444,"['ITPR1', 'LPP', 'VCL', 'MAPK3']",0.9999960853589026,0,0,4
166,LDLRAD4 and what we know about it WP4904,0.3276532977874,2.0903426791277258,2.3324027906398714,"['SMAD2', 'TGFBR1']",0.9999960853589026,0,0,2
167,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.3276532977874,2.0903426791277258,2.3324027906398714,"['AHCY', 'ADK']",0.9999960853589026,0,0,2
168,Pilocytic astrocytoma WP2253,0.3276532977874,2.0903426791277258,2.3324027906398714,"['NF1', 'RAF1']",0.9999960853589026,0,0,2
169,Role of Altered Glycolysation of MUC1 in Tumour Microenvironment WP4480,0.3276532977874,2.0903426791277258,2.3324027906398714,"['IKBKB', 'CHUK']",0.9999960853589026,0,0,2
170,Tamoxifen metabolism WP691,0.3276532977874,2.0903426791277258,2.3324027906398714,"['CYP2C8', 'CYP1B1']",0.9999960853589026,0,0,2
171,ATM Signaling Pathway WP2516,0.32879868400290324,1.2867351228006965,1.4312478532086401,"['PIDD1', 'CCNB1', 'ABL1', 'TLK1', 'MDM4', 'ATM', 'TP53', 'RAD9A']",0.9999960853589026,0,0,8
172,Proximal tubule transport WP4917,0.32879868400290324,1.2867351228006965,1.4312478532086401,"['ATP6V1A', 'SLC5A8', 'SLC2A1', 'SLC3A1', 'SLC16A10', 'ATP1A1', 'ATP1B1', 'ATP6V0C']",0.9999960853589026,0,0,8
173,Regulation of Microtubule Cytoskeleton WP2038,0.3341903559024756,1.2545880515423662,1.375084359378924,"['TIAM1', 'ROCK1', 'CFL2', 'MAP1B', 'TAOK1', 'DVL1', 'ABL1', 'PRKACA', 'CLASP1']",0.9999960853589026,0,0,9
174,IL-4 signaling pathway WP395,0.33838543635537577,1.2300091911764706,1.3328006766900475,"['IKBKB', 'CHUK', 'RPS6KB1', 'BAD', 'EP300', 'GAB2', 'CBL', 'MAPK14', 'JAK1', 'MAPK3']",0.9999960853589026,0,0,10
175,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.34029244556213173,1.3937621832358675,1.5024058019576754,"['IKBKB', 'CHUK', 'IRAK2', 'RASSF5', 'CBLB']",0.9999960853589026,0,0,5
176,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.34029244556213173,1.3937621832358675,1.5024058019576754,"['PRKAA1', 'GOT2', 'SLC2A1', 'TP53', 'SIRT2']",0.9999960853589026,0,0,5
177,NRF2-ARE regulation WP4357,0.34029244556213173,1.3937621832358675,1.5024058019576754,"['MAPK8', 'INSR', 'KEAP1', 'FYN', 'NFE2L2']",0.9999960853589026,0,0,5
178,Signal Transduction of S1P Receptor WP26,0.34029244556213173,1.3937621832358675,1.5024058019576754,"['AKT2', 'PLCB1', 'PLCB2', 'PIK3C2B', 'MAPK3']",0.9999960853589026,0,0,5
179,COVID-19 adverse outcome pathway WP4891,0.34890418147940583,4.180225768781627,4.401601939775952,['AGT'],0.9999960853589026,0,0,1
180,Tryptophan metabolism WP465,0.34955885713142665,1.320428606617949,1.3878804938040084,"['ALDH3A2', 'MAOB', 'TDO2', 'CYP1B1', 'DHCR24', 'CYP7B1']",0.9999960853589026,0,0,6
181,Male infertility WP4673,0.3522238920426734,1.140709603875748,1.1903170667586764,"['PACRG', 'INSR', 'XRCC3', 'UBR2', 'PEX10', 'SOD2', 'CLU', 'ETV5', 'PUM2', 'AR', 'CCNA1', 'EP300', 'SIRPA', 'ATM', 'NOS1', 'TRIP13', 'RAG1', 'NFE2L2']",0.9999960853589026,0,0,18
182,Integrated breast cancer pathway WP1984,0.3533875724392449,1.1073303879160787,1.1518338693302703,"['USP15', 'USP38', 'USP16', 'MYCBP2', 'DHTKD1', 'IMPA1', 'ABL1', 'EP300', 'JAK1', 'SMAD2', 'CHUK', 'BAD', 'NCOA3', 'XRCC3', 'PPP4R3A', 'TGFBR1', 'CDC25B', 'HIPK2', 'AR', 'ITPKC', 'NF1', 'ATM', 'ZNF655', 'MAP3K13', 'TP53', 'BMPR1A', 'ATR']",0.9999960853589026,0,0,27
183,Homologous recombination WP186,0.35963937498321785,1.5677834047526296,1.6032991637911886,"['RAD52', 'ATM', 'RAD54B']",0.9999960853589026,0,0,3
184,Hypertrophy Model WP516,0.35963937498321785,1.5677834047526296,1.6032991637911886,"['JUND', 'ADAM10', 'HBEGF']",0.9999960853589026,0,0,3
185,"GPCRs, Other WP117",0.3605373645717143,1.2389626160117964,1.263939707251095,"['CHRM3', 'GPR176', 'GPR88', 'OR2M4', 'GPR83', 'CELSR3', 'GPR135', 'ADGRL3']",0.9999960853589026,0,0,8
186,Exercise-induced Circadian Regulation WP410,0.3664210845090624,1.1947544642857142,1.1995001518151156,"['PER2', 'GSTM3', 'PSMA4', 'PPP1R3C', 'GSTP1', 'TAB2', 'ERC2', 'QKI', 'HERPUD1', 'ETV6']",0.9999960853589026,0,0,10
187,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.3683057383475219,1.1794571196681396,1.1780911609131741,"['GRIA1', 'PPP2CA', 'MAP2K1', 'MAPK8', 'DVL1', 'NEFL', 'NEFM', 'NOS1', 'RAF1', 'CBL', 'NCK1']",0.9999960853589026,0,0,11
188,Amino Acid metabolism WP3925,0.3720417402137865,1.1405443871197296,1.1277123801289435,"['PDHX', 'OAT', 'HIBADH', 'MCCC1', 'GOT2', 'ACLY', 'LARS2', 'PKM', 'PC', 'TDO2', 'AUH', 'ALDH18A1', 'BCAT1', 'DLD', 'FARSB']",0.9999960853589026,0,0,15
189,Retinoblastoma gene in cancer WP2446,0.3720417402137865,1.1405443871197296,1.1277123801289435,"['FAF1', 'RPA2', 'DCK', 'SMARCA2', 'SMC2', 'CDC25B', 'MAPK13', 'NPAT', 'CCNB1', 'CDK6', 'MCM3', 'ABL1', 'ZNF655', 'RAF1', 'TP53']",0.9999960853589026,0,0,15
190,Genes related to primary cilium development (based on CRISPR) WP4536,0.37221240169258574,1.1117837225817024,1.098765419337226,"['DYNC2H1', 'TTC26', 'IFT172', 'CEP295', 'CEP120', 'TULP3', 'KATNB1', 'IFT80', 'CPLANE1', 'RPGRIP1L', 'BBS10', 'ARL13B', 'WDR60', 'KIAA0753', 'TRAPPC11', 'FGFR1OP', 'WDPCP', 'CEP192', 'PIBF1', 'BBS5', 'CEP44']",0.9999960853589026,0,0,21
191,One-carbon metabolism WP241,0.3742063151384701,1.3936087295401403,1.3698448980322058,"['AHCYL2', 'ALDH1L1', 'AHCY', 'DNMT3A']",0.9999960853589026,0,0,4
192,miRNA regulation of p53 pathway in prostate cancer WP3982,0.38232618597635526,1.3065302144249513,1.256204166205002,"['ZMAT3', 'EI24', 'SIAH1', 'ATM', 'TP53']",0.9999960853589026,0,0,5
193,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.38232618597635526,1.3065302144249513,1.256204166205002,"['P4HA1', 'SERPINF1', 'ITPR1', 'P3H2', 'LRP6']",0.9999960853589026,0,0,5
194,Folate Metabolism WP176,0.3872970353563966,1.2542901716068642,1.1897736834575412,"['AHCY', 'INSR', 'NOS1', 'HBA1', 'SOD2', 'TP53']",0.9999960853589026,0,0,6
195,Oxidation by Cytochrome P450 WP43,0.3872970353563966,1.2542901716068642,1.1897736834575412,"['CYP27A1', 'CYB5B', 'CYB5R1', 'CYP2C8', 'CYP1B1', 'CYP7B1']",0.9999960853589026,0,0,6
196,Target Of Rapamycin (TOR) Signaling WP1471,0.3904819502450153,1.2194693718298868,1.1467567214931187,"['RPTOR', 'PRKAA1', 'RRAGA', 'RPS6KB1', 'MAPKAP1', 'AKT1S1', 'PRKAG2']",0.9999960853589026,0,0,7
197,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.3925539836637141,1.194602431136389,1.1170502906230937,"['DDX58', 'BSG', 'EP300', 'NUP98', 'TANK', 'IFIT2', 'JAK1', 'HAVCR2']",0.9999960853589026,0,0,8
198,MECP2 and Associated Rett Syndrome WP3584,0.39526950030184055,1.132479468126711,1.0511532494964824,"['GRIA1', 'RBFOX1', 'FOXG1', 'TET2', 'TET1', 'FGF2', 'GPRIN1', 'TET3', 'NF1', 'SGK1', 'TARDBP', 'GRIA3', 'EZH2']",0.9999960853589026,0,0,13
199,DDX1 as a regulatory component of the Drosha microprocessor WP2942,0.4041960252421608,1.6721183800623054,1.5146973096860623,"['DDX1', 'ATM']",0.9999960853589026,0,0,2
200,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.4041960252421608,1.6721183800623054,1.5146973096860623,"['TCF4', 'RUNX2']",0.9999960853589026,0,0,2
201,Disorders of the Krebs cycle WP4236,0.4041960252421608,1.6721183800623054,1.5146973096860623,"['PDHX', 'DHTKD1']",0.9999960853589026,0,0,2
202,Ketogenesis and Ketolysis WP4742,0.4041960252421608,1.6721183800623054,1.5146973096860623,"['SLC2A1', 'SLC25A20']",0.9999960853589026,0,0,2
203,Supression of HMGB1 mediated inflammation by THBD WP4479,0.4041960252421608,1.6721183800623054,1.5146973096860623,"['IKBKB', 'CHUK']",0.9999960853589026,0,0,2
204,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.417084644540802,1.3934553954031943,1.2185294957664463,"['TRPC1', 'ITPR1', 'PLCB1']",0.9999960853589026,0,0,3
205,Ganglio Sphingolipid Metabolism WP1423,0.417084644540802,1.3934553954031943,1.2185294957664463,"['B3GALT1', 'B3GALT4', 'ST8SIA5']",0.9999960853589026,0,0,3
206,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.417084644540802,1.3934553954031943,1.2185294957664463,"['LRP1', 'TCF4', 'DKK3']",0.9999960853589026,0,0,3
207,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.4187266119068885,1.1044527120796055,0.9614670053581794,"['MAP2K1', 'BAD', 'FRS2', 'SLC16A10', 'MAPK14', 'RPTOR', 'RPS6KA6', 'RPS6KB1', 'AKT1S1', 'PRKG2', 'PRKACA', 'RAF1', 'PLCB1', 'TP53']",0.9999960853589026,0,0,14
208,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.4220933895913698,1.2862881467713891,1.1094604264421422,"['RAB5B', 'RRAS2', 'RAF1', 'MAPK3']",0.9999960853589026,0,0,4
209,7-oxo-C and 7beta-HC pathways WP5064,0.424228009184521,1.2295608301800252,1.0543289980720238,"['HSD11B1', 'CYP27A1', 'ACOT9', 'SCP2', 'ACOT11']",0.9999960853589026,0,0,5
210,Integrated Cancer Pathway WP1971,0.4246276589658775,1.1533015693558373,0.9878519139654091,"['SMAD2', 'POU2F1', 'BAD', 'ATM', 'TP53', 'JAK1', 'CDC25B', 'ATR']",0.9999960853589026,0,0,8
211,GABA receptor Signaling WP4159,0.42500220574949993,1.1944506351682638,1.022044729469097,"['GABRB3', 'GABBR2', 'GABRA1', 'GABRG3', 'GPHN', 'GABRG2']",0.9999960853589026,0,0,6
212,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.42500220574949993,1.1944506351682638,1.022044729469097,"['CAMK2D', 'STAR', 'ITPR1', 'CAMK2G', 'PLCB2', 'AGT']",0.9999960853589026,0,0,6
213,Disruption of postsynaptic signaling by CNV WP4875,0.4250351833326492,1.1705813499804916,1.0015298884830057,"['CAMK2D', 'DLG1', 'NRXN3', 'DLGAP1', 'CAMK2G', 'MAPK3', 'SHANK1']",0.9999960853589026,0,0,7
214,Hedgehog Signaling Pathway WP4249,0.4250351833326492,1.1705813499804916,1.0015298884830057,"['CSNK1G3', 'SMURF1', 'GPR161', 'SPOP', 'SPOPL', 'ARRB1', 'PRKACA']",0.9999960853589026,0,0,7
215,B Cell Receptor Signaling Pathway WP23,0.4403826293835983,1.0812470477090221,0.8867429410861934,"['MAP2K1', 'CHUK', 'PDPK1', 'NFATC3', 'BCL10', 'GAB2', 'CBL', 'MAPK14', 'MALT1', 'IKBKB', 'MAPK8', 'FYN', 'RAF1', 'MAP3K7', 'NCK1']",0.9999960853589026,0,0,15
216,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.4403826293835983,1.0812470477090221,0.8867429410861934,"['PDGFRA', 'MAP2K1', 'SHC3', 'PDPK1', 'BAD', 'PDGFB', 'RRAS2', 'NRG2', 'FGF2', 'RPS6KB1', 'AKT2', 'NF1', 'RAF1', 'JAK1', 'MAPK3']",0.9999960853589026,0,0,15
217,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.4513977133990816,1.100123355263158,0.8750452457817517,"['IKBKB', 'CAMK2D', 'MAPK8', 'PLCB1', 'MAPK14', 'PLCB2', 'CAMK2G', 'JAK1', 'MAPK3', 'MAPK13']",0.9999960853589026,0,0,10
218,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.45390528404177993,1.1065760158026505,0.8740475770676152,"['SMAD2', 'TGFB2', 'MAP2K1', 'MAP3K9', 'SYNE3', 'SYNE1', 'ADCY5', 'MAPK3', 'PLEC']",0.9999960853589026,0,0,9
219,Modulators of TCR signaling and T cell activation WP5072,0.45390528404177993,1.1065760158026505,0.8740475770676152,"['IKBKB', 'CHUK', 'PDPK1', 'RASA2', 'ARIH2', 'CBLB', 'BCL10', 'MAP3K14', 'MALT1']",0.9999960853589026,0,0,9
220,Gastrin signaling pathway WP4659,0.45540935476550226,1.0598812309594243,0.8336586799116235,"['CHGA', 'MAP2K1', 'CHUK', 'ROCK1', 'BAD', 'ARHGEF28', 'ARRB1', 'MAPK14', 'HDAC7', 'IKBKB', 'MAPK8', 'RPS6KB1', 'TCF4', 'FYN', 'PRKACA', 'RAF1', 'LAMTOR3', 'MAPK3']",0.9999960853589026,0,0,18
221,Metapathway biotransformation Phase I and II WP702,0.45540935476550226,1.0598812309594243,0.8336586799116235,"['GSTM4', 'GSTM3', 'NAA30', 'GSTP1', 'MGST2', 'HS3ST5', 'GLYAT', 'KCNAB2', 'CYP7B1', 'NAT14', 'HS6ST2', 'HS6ST3', 'CYP27A1', 'CYP2C8', 'NDST3', 'CYP1B1', 'CHST1', 'NAT8L']",0.9999960853589026,0,0,18
222,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.45935340934195495,1.1254539451964345,0.8755304765080401,"['GABRB3', 'NTRK2', 'GABRA1', 'SLC12A5', 'ROCK1', 'GABRG3', 'GABRG2']",0.9999960853589026,0,0,7
223,Neural Crest Cell Migration in Cancer WP4565,0.45935340934195495,1.1254539451964345,0.8755304765080401,"['NTRK2', 'TIAM1', 'SORT1', 'KIDINS220', 'AKT2', 'PIK3R4', 'PAK2']",0.9999960853589026,0,0,7
224,Hepatitis B infection WP4666,0.4626452794623465,1.0451511582253632,0.805596924961748,"['MAP2K3', 'SMAD2', 'MAP2K1', 'TGFB2', 'MAP3K1', 'ATP6AP1', 'CHUK', 'DDX58', 'BAD', 'NFATC3', 'MAPK14', 'TGFBR1', 'MAPK13', 'IKBKB', 'MAPK8', 'AKT2', 'VDAC3', 'EP300', 'TAB2', 'RAF1', 'MAP3K7', 'JAK1', 'MAPK3']",0.9999960853589026,0,0,23
225,16p11.2 distal deletion syndrome WP4950,0.4655555704505978,1.161143599740091,0.8877219304653569,"['RAB4A', 'RABEP2', 'INSR', 'TUFM', 'SDCCAG8']",0.9999960853589026,0,0,5
226,Cannabinoid receptor signaling WP3869,0.4655555704505978,1.161143599740091,0.8877219304653569,"['MAPK8', 'PRKACA', 'MAPK14', 'MAPK3', 'MAPK13']",0.9999960853589026,0,0,5
227,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.4655555704505978,1.161143599740091,0.8877219304653569,"['VMP1', 'LATS1', 'RASSF5', 'STK38L', 'MAPK14']",0.9999960853589026,0,0,5
228,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.46901732851624495,1.1942990758267453,0.904222417689632,"['H2AFV', 'DUSP6', 'MAPK3', 'EZH2']",0.9999960853589026,0,0,4
229,Heart Development WP1591,0.46901732851624495,1.1942990758267453,0.904222417689632,"['HEY1', 'BHLHE40', 'NFATC3', 'BMPR1A']",0.9999960853589026,0,0,4
230,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.46901732851624495,1.1942990758267453,0.904222417689632,"['PIK3R4', 'ATG13', 'ATG7', 'ATG5']",0.9999960853589026,0,0,4
231,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.46901732851624495,1.1942990758267453,0.904222417689632,"['MAP2K1', 'ITPR1', 'RAF1', 'MAPK3']",0.9999960853589026,0,0,4
232,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.46901732851624495,1.1942990758267453,0.904222417689632,"['MAP2K1', 'RPS6KA5', 'GNAS', 'MAPK3']",0.9999960853589026,0,0,4
233,Zinc homeostasis WP3529,0.46901732851624495,1.1942990758267453,0.904222417689632,"['SLC30A7', 'SLC39A11', 'SLC39A7', 'SLC39A14']",0.9999960853589026,0,0,4
234,Head and Neck Squamous Cell Carcinoma WP4674,0.472321846775283,1.0672899372847804,0.8005684687639743,"['RPTOR', 'NOTCH2', 'PRKAA1', 'CDK6', 'MAML1', 'PDPK1', 'AKT2', 'MAPKAP1', 'KEAP1', 'CSMD3', 'TP53', 'NFE2L2']",0.9999960853589026,0,0,12
235,BMP Signaling Pathway in Eyelid Development WP3927,0.4727121230353059,1.2539929879236462,0.9395776897885907,"['MAP3K1', 'SMAD5', 'MAPK3']",0.9999960853589026,0,0,3
236,Cori Cycle WP1946,0.4727121230353059,1.2539929879236462,0.9395776897885907,"['PGAM1', 'SLC2A1', 'HK1']",0.9999960853589026,0,0,3
237,IL-9 signaling pathway WP22,0.4727121230353059,1.2539929879236462,0.9395776897885907,"['MAP2K1', 'MAPK3', 'JAK1']",0.9999960853589026,0,0,3
238,Phytochemical activity on NRF2 transcriptional activation WP3,0.4727121230353059,1.2539929879236462,0.9395776897885907,"['MAPK8', 'KEAP1', 'NFE2L2']",0.9999960853589026,0,0,3
239,TP53 network WP1742,0.4727121230353059,1.2539929879236462,0.9395776897885907,"['ABL1', 'ATM', 'TP53']",0.9999960853589026,0,0,3
240,Transcription co-factors SKI and SKIL protein partners WP4533,0.4727121230353059,1.2539929879236462,0.9395776897885907,"['LATS1', 'NF1', 'MERTK']",0.9999960853589026,0,0,3
241,Gene regulatory network modelling somitogenesis  WP2854,0.4746416167145536,2.0899182561307903,1.5573971591259164,['EPHA4'],0.9999960853589026,0,0,1
242,SARS-CoV-2 and angiotensin-converting enzyme 2 receptor: molecular mechanisms WP4883,0.4746416167145536,2.0899182561307903,1.5573971591259164,['AGT'],0.9999960853589026,0,0,1
243,Acute viral myocarditis WP4298,0.4757839708742851,1.069340312803875,0.7942967564459467,"['SGCD', 'ENDOG', 'RASA1', 'JKAMP', 'ABL1', 'DMD', 'FYN', 'NOS1', 'JAK1', 'MAPK3', 'EIF4G1']",0.9999960853589026,0,0,11
244,Neural Crest Differentiation WP2064,0.4757839708742851,1.069340312803875,0.7942967564459467,"['CDH6', 'NOTCH2', 'HDAC4', 'CTBP2', 'DVL1', 'TCF4', 'HDAC8', 'FGF2', 'HDAC9', 'HDAC6', 'HDAC7']",0.9999960853589026,0,0,11
245,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.4757839708742851,1.069340312803875,0.7942967564459467,"['IKBKB', 'MAPK8', 'CHUK', 'BAD', 'RASA1', 'NOS1', 'MAPK14', 'TP53', 'NCK1', 'MAPK3', 'MAPK13']",0.9999960853589026,0,0,11
246,Ebola Virus Pathway on Host WP4217,0.476119342887936,1.0450626959247649,0.7755271647491988,"['VPS18', 'GSN', 'DDX58', 'CLTC', 'VPS4A', 'DAB2IP', 'IQGAP1', 'MERTK', 'TPCN2', 'TIAM1', 'RASA2', 'VPS41', 'TYRO3', 'EP300', 'FLNB', 'TOP1', 'HAVCR2', 'MAPK3']",0.9999960853589026,0,0,18
247,15q13.3 copy number variation syndrome WP4942,0.47625750347783563,1.3933021806853583,1.033546816686682,"['OTUD7A', 'FYN']",0.9999960853589026,0,0,2
248,ATR Signaling WP3875,0.47625750347783563,1.3933021806853583,1.033546816686682,"['RAD9A', 'ATR']",0.9999960853589026,0,0,2
249,Canonical NF-KB pathway WP4562,0.47625750347783563,1.3933021806853583,1.033546816686682,"['IKBKB', 'CHUK']",0.9999960853589026,0,0,2
250,"Degradation pathway of sphingolipids, including diseases WP4153",0.47625750347783563,1.3933021806853583,1.033546816686682,"['HEXB', 'NEU1']",0.9999960853589026,0,0,2
251,Heme Biosynthesis WP561,0.47625750347783563,1.3933021806853583,1.033546816686682,"['UROD', 'UROS']",0.9999960853589026,0,0,2
252,IL1 and megakaryocytes in obesity WP2865,0.47625750347783563,1.3933021806853583,1.033546816686682,"['TIMP2', 'HBEGF']",0.9999960853589026,0,0,2
253,TFs regulate miRNAs related to cardiac hypertrophy WP1559,0.47625750347783563,1.3933021806853583,1.033546816686682,"['MYEF2', 'AKT2']",0.9999960853589026,0,0,2
254,G1 to S cell cycle control WP45,0.479525678297442,1.0718149038461537,0.787738760025271,"['CCNA1', 'PRIM2', 'CCNB1', 'CDK6', 'CCNG2', 'MCM3', 'RPA2', 'ATM', 'MNAT1', 'TP53']",0.9999960853589026,0,0,10
255,Wnt signaling pathway and pluripotency WP399,0.48589833899323875,1.0450097847358122,0.7542419316987565,"['CTBP2', 'LRRK2', 'PPP2R2A', 'PPP2R5C', 'LRP6', 'PPP2CA', 'PTPA', 'PPP2R1B', 'PPP2R1A', 'PPP2R2B', 'DVL1', 'EP300', 'MAP3K7', 'TP53', 'WNT2']",0.9999960853589026,0,0,15
256,16p11.2 proximal deletion syndrome WP4949,0.49348608960385504,1.0449745795854517,0.7380243816426157,"['UNC13B', 'MAP2K3', 'PAXIP1', 'SIAH1', 'PPP4R3A', 'PPP2R5D', 'PPP2CA', 'PPP4R1', 'PPP4C', 'PPP2R1A', 'TP53', 'YPEL3', 'MAPK3']",0.9999960853589026,0,0,13
257,Melanoma WP4685,0.497712123761679,1.0449569976544175,0.7291014341853185,"['GRM3', 'MAP2K1', 'CDK6', 'BAD', 'AKT2', 'NF1', 'POLK', 'RAF1', 'TP53', 'LAMTOR3', 'VCL', 'MAPK3']",0.9999960853589026,0,0,12
258,MET in type 1 papillary renal cell carcinoma WP4205,0.5023008726962921,1.0449394294646346,0.719499304209332,"['RAP1B', 'MAP2K1', 'MAPK8', 'BAD', 'AKT2', 'ELOA', 'STRN', 'RAF1', 'CBL', 'PAK2', 'MAPK3']",0.9999960853589026,0,0,11
259,Wnt signaling WP428,0.5084239528734406,1.0277822334862532,0.6952326301929587,"['CAMK2D', 'CTBP2', 'SERPINF1', 'CHD8', 'NFATC3', 'PRICKLE1', 'LRP6', 'MAPK8', 'PPP3CC', 'DVL1', 'PLCB1', 'MAP3K7', 'WNT2', 'PLCB2', 'CAMK2G']",0.9999960853589026,0,0,15
260,DNA IR-damage and cellular response via ATR WP4016,0.5128560236429772,1.0265628860884606,0.6854977651068203,"['SMARCAL1', 'POLN', 'CEP164', 'XPA', 'RPA2', 'PALB2', 'SEM1', 'RAD52', 'HERC2', 'UIMC1', 'ATM', 'TP53', 'RAD9A', 'ATR']",0.9999960853589026,0,0,14
261,Imatinib and Chronic Myeloid Leukemia WP3640,0.5257622065567228,1.139887381804016,0.7328407189259288,"['PDGFRA', 'ABL1', 'GAB2']",0.9999960853589026,0,0,3
262,MAPK pathway in congenital thyroid cancer WP4928,0.5257622065567228,1.139887381804016,0.7328407189259288,"['MAP2K1', 'RAF1', 'MAPK3']",0.9999960853589026,0,0,3
263,NAD+ metabolism WP3644,0.5257622065567228,1.139887381804016,0.7328407189259288,"['NMNAT3', 'SIRT7', 'SIRT2']",0.9999960853589026,0,0,3
264,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.5257622065567228,1.139887381804016,0.7328407189259288,"['IKBKB', 'EGLN2', 'CHUK']",0.9999960853589026,0,0,3
265,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.5257622065567228,1.139887381804016,0.7328407189259288,"['IKBKB', 'CHUK', 'ITPR1']",0.9999960853589026,0,0,3
266,Fas ligand pathway and stress induction of heat shock proteins WP314,0.5263667878840704,1.0448692937963324,0.6705521769914311,"['MAPK8', 'DAXX', 'MAP3K1', 'FAF1', 'LMNA', 'PAK2', 'MAP3K7']",0.9999960853589026,0,0,7
267,Hepatitis C and Hepatocellular Carcinoma WP3646,0.5263667878840704,1.0448692937963324,0.6705521769914311,"['MAPK8', 'CTTN', 'MAPK14', 'TP53', 'TGFBR1', 'JAK1', 'MAPK3']",0.9999960853589026,0,0,7
268,IL-6 signaling pathway WP364,0.5263667878840704,1.0448692937963324,0.6705521769914311,"['MAP2K1', 'RPS6KB1', 'BAD', 'MAP3K7', 'AGT', 'JAK1', 'MAPK3']",0.9999960853589026,0,0,7
269,Toll-like Receptor Signaling Pathway WP75,0.5284534567673663,1.0216230298293605,0.6515917244080334,"['MAP2K3', 'IKBKB', 'MAP2K1', 'MAPK8', 'CHUK', 'AKT2', 'TAB2', 'MAPK14', 'MAP3K7', 'MAPK3', 'MAPK13']",0.9999960853589026,0,0,11
270,AGE/RAGE pathway WP2324,0.534692716437822,1.0193407012195121,0.6381715574601513,"['IKBKB', 'SMAD2', 'MAP2K1', 'MAPK8', 'CHUK', 'ROCK1', 'INSR', 'RAF1', 'MAPK14', 'MAPK3']",0.9999960853589026,0,0,10
271,Bladder cancer WP2828,0.5347979906170904,1.0448517940717628,0.6539374125380892,"['MAP2K1', 'RPS6KA5', 'DAPK2', 'RAF1', 'TP53', 'HBEGF']",0.9999960853589026,0,0,6
272,Autosomal recessive Osteopetrosis pathways WP4788,0.5427143498720248,1.1941477525589674,0.7298298572704077,"['IKBKB', 'PLEKHM1']",0.9999960853589026,0,0,2
273,IL17 signaling pathway WP2112,0.5450177058509001,1.0448343079922027,0.6341485973042519,"['IKBKB', 'MAP3K7', 'MAP3K14', 'JAK1', 'MAPK3']",0.9999960853589026,0,0,5
274,Osteoblast differentiation WP4787,0.5472485306575438,0.9979546278006989,0.6016191703527949,"['NOTCH2', 'PIK3R4', 'PIK3C2A', 'MAPK14', 'FGF2', 'SMAD5', 'RUNX2', 'PIK3C2B', 'LRP6', 'MAPK13', 'MAPK8', 'FGF9', 'HEY1', 'WNT2', 'BMPR1A', 'MAPK3']",0.9999960853589026,0,0,16
275,Prolactin Signaling Pathway WP2037,0.5474980415476134,1.0029710711493354,0.6041861569276693,"['PTPN1', 'MAP2K1', 'MAPK8', 'RPS6KB1', 'SIRPA', 'FYN', 'GAB2', 'RAF1', 'CBL', 'MAPK14', 'JAK1', 'MAPK3']",0.9999960853589026,0,0,12
276,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.5495552297728586,1.013128947555177,0.6065055930002669,"['MAP2K3', 'PDGFRA', 'MAPK8', 'MAPK14', 'TP53', 'HBEGF', 'MAPK13', 'NFE2L2']",0.9999960853589026,0,0,8
277,Endometrial cancer WP4155,0.554144314830082,0.9993203866999677,0.5899289338670777,"['APC2', 'MAP2K1', 'PDPK1', 'BAD', 'AKT2', 'POLK', 'CTNNA2', 'RAF1', 'FGF2', 'TP53', 'MAPK3']",0.9999960853589026,0,0,11
278,EPO Receptor Signaling WP581,0.5579965389716133,1.0448168355416991,0.6095487739365932,"['MAP2K1', 'RASA1', 'RAF1', 'MAPK3']",0.9999960853589026,0,0,4
279,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.5665737142143076,0.9831603229527105,0.558580654537327,"['MAP2K3', 'NOTCH2', 'SMAD2', 'MAP2K1', 'TGFB2', 'NUBPL', 'EIF5A2', 'MAPK14', 'TGFBR1', 'LRP6', 'MAPK13', 'ZEB2', 'MAPK8', 'AKT2', 'CLDN12', 'RAF1', 'TP53', 'WNT2', 'EZH2', 'MAPK3']",0.9999960853589026,0,0,20
280,Oxidative Damage WP3941,0.5694338201838519,1.0029641185647427,0.5647818425608448,"['C5', 'MAP3K1', 'BAD', 'TNK2', 'MAP3K9', 'MAPK13']",0.9999960853589026,0,0,6
281,p53 transcriptional gene network WP4963,0.5697458300283761,0.9897244086397172,0.556784242500295,"['PIDD1', 'RRM2B', 'ZMAT3', 'ADGRB1', 'CCNG1', 'SLC2A1', 'POLK', 'CPT1C', 'CX3CL1']",0.9999960853589026,0,0,9
282,Overview of interferons-mediated signaling pathway WP4558,0.5757047970451439,1.0447993767043242,0.576896690047423,"['IL10RB', 'IFNLR1', 'JAK1']",0.9999960853589026,0,0,3
283,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.5757047970451439,1.0447993767043242,0.576896690047423,"['ACLY', 'PC', 'DLD']",0.9999960853589026,0,0,3
284,Benzene metabolism WP3891,0.576104640611988,1.393149085247178,0.7682743075499693,['DHDH'],0.9999960853589026,0,0,1
285,Cells and molecules involved in local acute inflammatory response  WP4493,0.576104640611988,1.393149085247178,0.7682743075499693,['C5'],0.9999960853589026,0,0,1
286,Codeine and Morphine Metabolism WP1604,0.576104640611988,1.393149085247178,0.7682743075499693,['CYP2C8'],0.9999960853589026,0,0,1
287,FTO Obesity Variant Mechanism WP3407,0.576104640611988,1.393149085247178,0.7682743075499693,['FTO'],0.9999960853589026,0,0,1
288,Irinotecan pathway WP229,0.576104640611988,1.393149085247178,0.7682743075499693,['ABCC1'],0.9999960853589026,0,0,1
289,miR-517 relationship with ARCN1 and USP1 WP3596,0.576104640611988,1.393149085247178,0.7682743075499693,['ARCN1'],0.9999960853589026,0,0,1
290,Nucleotide GPCRs WP80,0.576104640611988,1.393149085247178,0.7682743075499693,['ADORA1'],0.9999960853589026,0,0,1
291,Platelet-mediated interactions with vascular and circulating cells WP4462,0.576104640611988,1.393149085247178,0.7682743075499693,['TGFB2'],0.9999960853589026,0,0,1
292,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.576104640611988,1.393149085247178,0.7682743075499693,['EPHA4'],0.9999960853589026,0,0,1
293,Vitamin B6-dependent and responsive disorders WP4228,0.576104640611988,1.393149085247178,0.7682743075499693,['PNPO'],0.9999960853589026,0,0,1
294,Endothelin Pathways WP2197,0.5825702229390766,0.9949874686716792,0.537597247928303,"['MAP2K1', 'GNAS', 'ECE1', 'RAF1', 'PLCB1']",0.9999960853589026,0,0,5
295,Nanoparticle-mediated activation of receptor signaling WP2643,0.5825702229390766,0.9949874686716792,0.537597247928303,"['MAPK8', 'MAP2K1', 'MAPK14', 'RAF1', 'MAPK13']",0.9999960853589026,0,0,5
296,Oxysterols derived from cholesterol WP4545,0.5825702229390766,0.9949874686716792,0.537597247928303,"['CYP27A1', 'ACOT9', 'SCP2', 'ACOT11', 'CYP7B1']",0.9999960853589026,0,0,5
297,IL-18 signaling pathway WP4754,0.5873148760022983,0.9728296097835012,0.5177342635568692,"['PRKAA1', 'PIGT', 'MEPCE', 'ENO1', 'PTMS', 'TMEM165', 'RPTOR', 'IKBKB', 'ABHD16A', 'GRM7', 'BSG', 'NFKBIZ', 'LONP2', 'TRPM7', 'LRRFIP1', 'RPS11', 'MAP3K7', 'MAPK3', 'USP5', 'CHUK', 'BAD', 'TACR1', 'FOXN3', 'TRPC4AP', 'RUNX2', 'LARS2', 'UCK1', 'RPS6KB1', 'CLDN12', 'HDGF', 'KIFC3', 'TP53', 'APBA2', 'ARF6']",0.9999960853589026,0,0,34
298,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.5954102117919677,0.9642148312984904,0.499949901977218,"['APC2', 'SMAD2', 'MAP2K1', 'MAPK8', 'TGFB2', 'BAD', 'AKT2', 'POLK', 'RAF1', 'TP53', 'TGFBR1', 'MAPK3']",0.9999960853589026,0,0,12
299,Genotoxicity pathway WP4286,0.5970569177124193,0.9642567506683086,0.4973085059977357,"['ITPKC', 'RRM2B', 'EI24', 'PCDH8', 'ITPR1', 'CBLB', 'TM7SF3', 'SMAD5', 'TRIM22']",0.9999960853589026,0,0,9
300,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.5993307113815711,0.9832653248360919,0.5033745488976865,"['SMAD2', 'TGFB2', 'RAF1', 'TGFBR1']",0.9999960853589026,0,0,4
301,White fat cell differentiation WP4149,0.5993307113815711,0.9832653248360919,0.5033745488976865,"['KLF5', 'RORA', 'ZNF423', 'KLF15']",0.9999960853589026,0,0,4
302,Signaling of Hepatocyte Growth Factor Receptor WP313,0.6027565608206142,0.9642985719428777,0.48816831921058657,"['RAP1B', 'MAPK8', 'MAP2K1', 'RASA1', 'RAF1', 'MAPK3']",0.9999960853589026,0,0,6
303,Cysteine and methionine catabolism WP4504,0.6030437541150099,1.0447819314641744,0.5284146812060856,"['AHCY', 'SUOX']",0.9999960853589026,0,0,2
304,Nanoparticle triggered regulated necrosis WP2513,0.6030437541150099,1.0447819314641744,0.5284146812060856,"['MAPK8', 'FTL']",0.9999960853589026,0,0,2
305,Osteoclast Signaling WP12,0.6030437541150099,1.0447819314641744,0.5284146812060856,"['MAPK8', 'PDGFB']",0.9999960853589026,0,0,2
306,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.6030437541150099,1.0447819314641744,0.5284146812060856,"['RNASEH2C', 'DDX58']",0.9999960853589026,0,0,2
307,TCA cycle in senescence WP5050,0.6030437541150099,1.0447819314641744,0.5284146812060856,"['ME2', 'TP53']",0.9999960853589026,0,0,2
308,Transcriptional cascade regulating adipogenesis WP4211,0.6030437541150099,1.0447819314641744,0.5284146812060856,"['KLF5', 'KLF15']",0.9999960853589026,0,0,2
309,Breast cancer pathway WP4262,0.6033671289388792,0.9603786342123056,0.4852115500849075,"['NOTCH2', 'APC2', 'MAP2K1', 'SHC3', 'NCOA3', 'FGF2', 'LRP6', 'CDK6', 'FGF9', 'HEY1', 'RPS6KB1', 'AKT2', 'DVL1', 'ATM', 'POLK', 'RAF1', 'TP53', 'WNT2', 'ATR', 'MAPK3']",0.9999960853589026,0,0,20
310,ESC Pluripotency Pathways WP3931,0.6091662956902165,0.9549166573442219,0.4733177957379369,"['ACVR1', 'MAP2K3', 'PDGFRA', 'MAP2K1', 'PDGFB', 'FGF2', 'SMAD5', 'LRP6', 'FGF9', 'AKT2', 'DVL1', 'RAF1', 'WNT2', 'MAP2K5', 'BMPR1A', 'JAK1']",0.9999960853589026,0,0,16
311,Calcium Regulation in the Cardiac Cell WP536,0.6098677913379155,0.9573194662480377,0.4734069985803355,"['CHRM3', 'GNAZ', 'RGS17', 'CAMK2D', 'CHRM5', 'ITPR1', 'CACNA1A', 'ARRB1', 'ATP1B1', 'ADCY5', 'SLC8A3', 'RGS2', 'STIM2', 'GRK4', 'PRKAR2A', 'GNAS', 'ANXA6', 'CASQ1', 'PRKACA', 'CAMK2G', 'RGS6', 'KCNJ3']",0.9999960853589026,0,0,22
312,G Protein Signaling Pathways WP35,0.6162098522494504,0.9494751823518947,0.45970521925991004,"['GNAZ', 'PDE1C', 'PDE1A', 'ITPR1', 'ADCY5', 'AKAP12', 'PPP3CC', 'PRKAR2A', 'AKAP9', 'GNAS', 'ARHGEF1', 'PDE7B', 'PRKACA', 'PDE8A', 'KCNJ3']",0.9999960853589026,0,0,15
313,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.6183811105619222,0.949672160198476,0.4564602351385701,"['IKBKB', 'CHUK', 'CARD9', 'NOD1', 'AAMP']",0.9999960853589026,0,0,5
314,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.6183811105619222,0.949672160198476,0.4564602351385701,"['SMAD2', 'NOS1', 'RAF1', 'TGFBR1', 'MCU']",0.9999960853589026,0,0,5
315,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.6222044110641781,0.9643402954661233,0.45756655293780524,"['PRXL2B', 'PLA2G6', 'PTGR2']",0.9999960853589026,0,0,3
316,Methionine De Novo and Salvage Pathway WP3580,0.6222044110641781,0.9643402954661233,0.45756655293780524,"['MSRA', 'AHCY', 'MSRB3']",0.9999960853589026,0,0,3
317,Senescence and Autophagy in Cancer WP615,0.6237874520954466,0.9433338381543743,0.445202245078251,"['MAP2K3', 'MAP2K1', 'GSN', 'KMT2A', 'BMI1', 'MAPK14', 'ATG13', 'CDC25B', 'LAMP1', 'AKT1S1', 'RAF1', 'TP53', 'ATG7', 'ATG5']",0.9999960853589026,0,0,14
318,Corticotropin-releasing hormone signaling pathway WP2355,0.6319829990471503,0.9363478213963022,0.42968325990024014,"['GNAZ', 'MAP2K1', 'JUND', 'ARRB1', 'ECE1', 'MAPK14', 'RAP1B', 'MAPK8', 'STAR', 'GNAS', 'TCF4', 'RAF1', 'MAPK3']",0.9999960853589026,0,0,13
319,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.634623904744819,0.9284971398855955,0.4222087556819536,"['LATS1', 'MAPK8', 'SGMS1', 'ITGB8', 'PAK2', 'MAP4K4']",0.9999960853589026,0,0,6
320,Notch Signaling WP268,0.634623904744819,0.9284971398855955,0.4222087556819536,"['NOTCH2', 'CTBP2', 'MAML1', 'DVL1', 'PSEN1', 'MAML3']",0.9999960853589026,0,0,6
321,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.6353114983148089,0.9284413218839448,0.4211779837032213,"['PPP1CC', 'PPP1R3F', 'MAPK8', 'PPP1R14B', 'PPP1R3C', 'PPP1R9A', 'PPP1R12B', 'ATF6']",0.9999960853589026,0,0,8
322,Phosphodiesterases in neuronal function WP4222,0.6353114983148089,0.9284413218839448,0.4211779837032213,"['GRIA1', 'GUCY1A2', 'PDE1C', 'PDE1A', 'NOS1', 'PDE7B', 'PDE8A', 'ADCY5']",0.9999960853589026,0,0,8
323,Nanoparticle triggered autophagic cell death WP2509,0.6382423925404105,0.928552870875552,0.4169547274999516,"['VMP1', 'INSR', 'ATG7', 'ATG5']",0.9999960853589026,0,0,4
324,Endochondral Ossification with Skeletal Dysplasias WP4808,0.6489240914172859,0.9139192352711666,0.39521480592561065,"['HDAC4', 'TGFB2', 'ENPP1', 'PRKACA', 'FGF2', 'RUNX2', 'BMPR1A']",0.9999960853589026,0,0,7
325,Endochondral Ossification WP474,0.6489240914172859,0.9139192352711666,0.39521480592561065,"['HDAC4', 'TGFB2', 'ENPP1', 'PRKACA', 'FGF2', 'RUNX2', 'BMPR1A']",0.9999960853589026,0,0,7
326,Metabolic reprogramming in colon cancer WP4290,0.6489240914172859,0.9139192352711666,0.39521480592561065,"['ACLY', 'PKM', 'PGAM1', 'GOT2', 'SLC2A1', 'ENO1', 'TKT']",0.9999960853589026,0,0,7
327,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.6506715840769176,0.919030871434154,0.39495374051678905,"['MAP2K3', 'RAP1B', 'MAP2K1', 'RPS6KB1', 'PDPK1', 'GNAS', 'RAF1', 'PLCB1', 'MAPK14', 'JAK1', 'MAPK3']",0.9999960853589026,0,0,11
328,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.6571335676085519,0.9286085150571132,0.38989298319964955,"['ENPP1', 'ROS1']",0.9999960853589026,0,0,2
329,GPR40 Pathway WP3958,0.6571335676085519,0.9286085150571132,0.38989298319964955,"['PLCB1', 'PLCB2']",0.9999960853589026,0,0,2
330,Leptin Insulin Overlap WP3935,0.6571335676085519,0.9286085150571132,0.38989298319964955,"['PDPK1', 'INSR']",0.9999960853589026,0,0,2
331,Mammalian disorder of sexual development WP4842,0.6571335676085519,0.9286085150571132,0.38989298319964955,"['FGF9', 'AMH']",0.9999960853589026,0,0,2
332,NO metabolism in cystic fibrosis WP4947,0.6571335676085519,0.9286085150571132,0.38989298319964955,"['PRMT3', 'NOS1']",0.9999960853589026,0,0,2
333,Acetylcholine Synthesis WP528,0.6579781030857755,1.0447644998053718,0.4373213128490565,['PCYT1A'],0.9999960853589026,0,0,1
334,Complement Activation WP545,0.6579781030857755,1.0447644998053718,0.4373213128490565,['C5'],0.9999960853589026,0,0,1
335,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.6579781030857755,1.0447644998053718,0.4373213128490565,['CYP2C8'],0.9999960853589026,0,0,1
336,LncRNA-mediated mechanisms of therapeutic resistance WP3672,0.6579781030857755,1.0447644998053718,0.4373213128490565,['TP53'],0.9999960853589026,0,0,1
337,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.6579781030857755,1.0447644998053718,0.4373213128490565,['HEY1'],0.9999960853589026,0,0,1
338,The alternative pathway of fetal androgen synthesis WP4524,0.6579781030857755,1.0447644998053718,0.4373213128490565,['STAR'],0.9999960853589026,0,0,1
339,Vitamin D Metabolism WP1531,0.6579781030857755,1.0447644998053718,0.4373213128490565,['CYP27A1'],0.9999960853589026,0,0,1
340,Ciliary landscape WP4352,0.6599934441842747,0.9394238358326756,0.39035444360834154,"['DOCK5', 'TTC26', 'POM121', 'DDX5', 'CTBP2', 'ZMYND19', 'IFT172', 'SSNA1', 'ANKS3', 'VPS4A', 'IQGAP1', 'EHBP1', 'APMAP', 'NEFL', 'STOM', 'NEFM', 'TMED1', 'NINL', 'BBS5', 'CEP290', 'IQCB1', 'RNGTT', 'EXOC8', 'NUP133', 'IFT80', 'EHD3', 'PSMC6', 'RABEP2', 'WDR60', 'PSMC4', 'VAPB', 'GID8', 'EXOC4', 'MCM3', 'EXOC3', 'ANKS6']",0.9999960853589026,0,0,36
341,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.6617771675575991,0.9032639196573623,0.37289117829824114,"['RPTOR', 'NTRK2', 'PRKAA1', 'RPS6KB1', 'AKT2', 'NF1', 'PRKAG2', 'MAPK3']",0.9999960853589026,0,0,8
342,Hippo-Yap signaling pathway WP4537,0.6650853061334588,0.8953753686905226,0.36516986050911476,"['LATS1', 'STK38L', 'MAP4K4']",0.9999960853589026,0,0,3
343,Purinergic signaling WP4900,0.6650853061334588,0.8953753686905226,0.36516986050911476,"['GNAZ', 'ADORA1', 'GNAS']",0.9999960853589026,0,0,3
344,Triacylglyceride synthesis WP325,0.6650853061334588,0.8953753686905226,0.36516986050911476,"['MOGAT1', 'AGPS', 'AGPAT4']",0.9999960853589026,0,0,3
345,Vitamin B12 metabolism WP1533,0.6650853061334588,0.8953753686905226,0.36516986050911476,"['INSR', 'HBA1', 'SOD2']",0.9999960853589026,0,0,3
346,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.6650853061334588,0.8953753686905226,0.36516986050911476,"['FLT3', 'LRP6', 'RUNX1T1']",0.9999960853589026,0,0,3
347,Oxidative Stress WP408,0.6745974807948546,0.8795996225950691,0.3462447956450294,"['NOX5', 'MAPK14', 'SOD2', 'NFE2L2']",0.9999960853589026,0,0,4
348,Wnt signaling in kidney disease WP4150,0.6745974807948546,0.8795996225950691,0.3462447956450294,"['MAPK8', 'DVL1', 'WNT2', 'LRP6']",0.9999960853589026,0,0,4
349,Androgen receptor signaling pathway WP138,0.6839931299829266,0.8995425544721319,0.34165292356617005,"['TGIF1', 'DAXX', 'ROCK1', 'NCOA3', 'LIMK2', 'RNF6', 'EFCAB6', 'PIAS2', 'ETV5', 'RUNX2', 'AR', 'ZNF318', 'EP300', 'RAD9A']",0.9999960853589026,0,0,14
350,miRNA regulation of prostate cancer signaling pathways WP3981,0.6842340236018912,0.8703703703703703,0.33026663268589945,"['AR', 'MAP2K1', 'BAD', 'RAF1', 'TP53']",0.9999960853589026,0,0,5
351,Pathogenic Escherichia coli infection WP2272,0.7025697974052953,0.8599986229372748,0.3035885670788109,"['CTTN', 'ROCK1', 'TUBB', 'ABL1', 'FYN', 'TUBB4A', 'NCK1']",0.9999960853589026,0,0,7
352,NAD+ biosynthetic pathways WP3645,0.704298861552523,0.835605765485002,0.2929236848042279,"['TDO2', 'SIRT7', 'SIRT2']",0.9999960853589026,0,0,3
353,Airway smooth muscle cell contraction WP4962,0.7051433009894142,0.8356697819314641,0.29194477571662375,"['ROCK1', 'PLCB1']",0.9999960853589026,0,0,2
354,Cancer immunotherapy by PD-1 blockade WP4585,0.7051433009894142,0.8356697819314641,0.29194477571662375,"['NFAT5', 'NFATC3']",0.9999960853589026,0,0,2
355,Cell Differentiation - Index expanded WP2023,0.7051433009894142,0.8356697819314641,0.29194477571662375,"['RUNX2', 'EZH2']",0.9999960853589026,0,0,2
356,Serotonin and anxiety WP3947,0.7051433009894142,0.8356697819314641,0.29194477571662375,"['GABRA1', 'PLCD4']",0.9999960853589026,0,0,2
357,Peptide GPCRs WP24,0.7083317525262348,0.8355416991426344,0.2881304705529729,"['OPRD1', 'TAC4', 'TACR1', 'SSTR3']",0.9999960853589026,0,0,4
358,Spinal Cord Injury WP2431,0.7125320750928562,0.8756102791830144,0.2967708985433165,"['EPHA4', 'SEMA6A', 'XYLT1', 'TACR1', 'PLA2G6', 'EFNB2', 'C5', 'CCNG1', 'PLXNA2', 'NOS1', 'ROS1', 'TP53', 'MAPK3']",0.9999960853589026,0,0,13
359,BDNF-TrkB Signaling WP3676,0.7141212006314199,0.8354775828460039,0.28130745956855774,"['NTRK2', 'MAP2K1', 'EEF2K', 'RPS6KB1', 'GAB2']",0.9999960853589026,0,0,5
360,Fatty acid beta-oxidation WP143,0.7141212006314199,0.8354775828460039,0.28130745956855774,"['HADHB', 'ACSL5', 'SLC25A20', 'CRAT', 'DLD']",0.9999960853589026,0,0,5
361,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.7141212006314199,0.8354775828460039,0.28130745956855774,"['PKM', 'SLC2A1', 'ARNT', 'TP53', 'HK1']",0.9999960853589026,0,0,5
362,ACE Inhibitor Pathway WP554,0.7240429860077852,0.835733748540288,0.2698622010925369,['AGT'],0.9999960853589026,0,0,1
363,Benzo(a)pyrene metabolism WP696,0.7240429860077852,0.835733748540288,0.2698622010925369,['CYP1B1'],0.9999960853589026,0,0,1
364,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.7240429860077852,0.835733748540288,0.2698622010925369,['SMAD5'],0.9999960853589026,0,0,1
365,Caloric restriction and aging WP4191,0.7240429860077852,0.835733748540288,0.2698622010925369,['TP53'],0.9999960853589026,0,0,1
366,Fluoroacetic acid toxicity WP4966,0.7240429860077852,0.835733748540288,0.2698622010925369,['ALDH3A2'],0.9999960853589026,0,0,1
367,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.7240429860077852,0.835733748540288,0.2698622010925369,['ALDH1L1'],0.9999960853589026,0,0,1
368,Glucuronidation WP698,0.7240429860077852,0.835733748540288,0.2698622010925369,['HK1'],0.9999960853589026,0,0,1
369,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.7240429860077852,0.835733748540288,0.2698622010925369,['TP53'],0.9999960853589026,0,0,1
370,Nephrogenesis WP5052,0.7240429860077852,0.835733748540288,0.2698622010925369,['NOTCH2'],0.9999960853589026,0,0,1
371,Peroxiredoxin 2 induced ovarian failure WP4873,0.7240429860077852,0.835733748540288,0.2698622010925369,['STAR'],0.9999960853589026,0,0,1
372,Selective expression of chemokine receptors during T-cell polarization WP4494,0.7240429860077852,0.835733748540288,0.2698622010925369,['TGFB2'],0.9999960853589026,0,0,1
373,Serotonin Transporter Activity WP1455,0.7240429860077852,0.835733748540288,0.2698622010925369,['NOS1'],0.9999960853589026,0,0,1
374,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.7270688594126362,0.8522799744897959,0.2716506810055945,"['APC2', 'CDK6', 'CTBP2', 'CHD8', 'SERPINF1', 'DVL1', 'MAP3K7', 'WNT2', 'LRP6', 'EZH2']",0.9999960853589026,0,0,10
375,Notch Signaling Pathway Netpath WP61,0.7339450000818429,0.8352849336455894,0.25837132544091784,"['NOTCH2', 'SPEN', 'HEY1', 'MAML1', 'FHL1', 'EP300', 'MAML3', 'PSEN1']",0.9999960853589026,0,0,8
376,22q11.2 copy number variation syndrome WP4657,0.7382367365121076,0.8596152075853816,0.2608852422609895,"['RTL10', 'CBX5', 'OAT', 'TANGO2', 'CHRD', 'KLHL22', 'MALT1', 'THAP7', 'DGCR6L', 'RAF1', 'TNPO1', 'DEPDC5', 'TP53', 'ASF1A']",0.9999960853589026,0,0,14
377,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.7398944048803373,0.7833073626801714,0.23596961900557292,"['BAD', 'MAPK14', 'MAPK13']",0.9999960853589026,0,0,3
378,Trans-sulfuration and one-carbon metabolism WP2525,0.7398944048803373,0.7833073626801714,0.23596961900557292,"['AHCYL2', 'AHCY', 'DNMT3A']",0.9999960853589026,0,0,3
379,IL-5 signaling pathway WP127,0.7419456663065314,0.8032688559004348,0.23975909730322376,"['MAP2K1', 'RPS6KB1', 'RAF1', 'JAK1', 'MAPK3']",0.9999960853589026,0,0,5
380,One-carbon metabolism and related pathways WP3940,0.7458681080857412,0.8083891097579387,0.23702493603082442,"['PCYT1A', 'DNMT3A', 'CEPT1', 'BCAT1', 'SOD2', 'BCAT2']",0.9999960853589026,0,0,6
381,Biomarkers for pyrimidine metabolism disorders WP4584,0.7474034620026174,0.7596290002832059,0.22116608209320598,"['RRM2B', 'DPYS']",0.9999960853589026,0,0,2
382,Tryptophan catabolism leading to NAD+ production WP4210,0.7474034620026174,0.7596290002832059,0.22116608209320598,"['TDO2', 'NMNAT3']",0.9999960853589026,0,0,2
383,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.7536397041965838,0.8940128537602886,0.2528633743071583,"['PFKFB4', 'PRKAA1', 'PHLPP1', 'CAB39L', 'PDGFB', 'PIK3R4', 'SLC2A1', 'PIK3C2A', 'FGF2', 'THBS4', 'PIK3C2B', 'THBS3', 'RPTOR', 'IKBKB', 'PPP2CA', 'GYS1', 'PPP2R1B', 'FGF9', 'PPP2R1A', 'AKT2', 'ITGB8', 'NOS1', 'JAK1', 'MAPK3', 'PDGFRA', 'MAP2K1', 'PDPK1', 'BAD', 'INSR', 'PPP2R5D', 'PPP2R5C', 'EFNA3', 'RPS6KB1', 'PPP2R2B', 'AKT1S1', 'RAF1']",0.9999960853589026,0,0,36
384,DNA IR-double strand breaks and cellular response via ATM WP3959,0.7554949421696577,0.8148359703737552,0.22846549547039433,"['LATS1', 'RAD52', 'CDK5', 'ABL1', 'ATM', 'TP53', 'RAD9A', 'ATR']",0.9999960853589026,0,0,8
385,Glycerophospholipid Biosynthetic Pathway WP2533,0.767960742814455,0.7594416495429746,0.20050525025904425,"['PTPMT1', 'IPMK', 'AGPS', 'CEPT1']",0.9999960853589026,0,0,4
386,The influence of laminopathies on Wnt signaling WP4844,0.767960742814455,0.7594416495429746,0.20050525025904425,"['ICMT', 'CDK6', 'LMNA', 'RUNX2']",0.9999960853589026,0,0,4
387,1q21.1 copy number variation syndrome WP4905,0.7719939852126614,0.7371617131464974,0.1907616172488882,"['PRKAA1', 'PRKAG2', 'TJP2']",0.9999960853589026,0,0,3
388,Complement and Coagulation Cascades WP558,0.7719939852126614,0.7371617131464974,0.1907616172488882,"['CLTC', 'SERPING1', 'CLU']",0.9999960853589026,0,0,3
389,Genes controlling nephrogenesis WP4823,0.7719939852126614,0.7371617131464974,0.1907616172488882,"['NOTCH2', 'PDGFB', 'NCK1']",0.9999960853589026,0,0,3
390,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.7719939852126614,0.7371617131464974,0.1907616172488882,"['YY1', 'PTPN1', 'CHUK']",0.9999960853589026,0,0,3
391,Glucocorticoid Receptor Pathway WP2880,0.7722969572987481,0.7900475582879016,0.20413734153575322,"['RGS2', 'NAV3', 'ABHD2', 'AMIGO2', 'BHLHE40', 'STOM', 'SLC19A2']",0.9999960853589026,0,0,7
392,Nucleotide Excision Repair WP4753,0.7722969572987481,0.7900475582879016,0.20413734153575322,"['CUL4A', 'XPA', 'RPA2', 'GTF2H1', 'ERCC6', 'MNAT1', 'RAD23B']",0.9999960853589026,0,0,7
393,Vitamin D Receptor Pathway WP2877,0.7761221346306892,0.8212614875863572,0.20814493078244317,"['CRACR2A', 'TGFB2', 'CEACAM1', 'BGLAP', 'CLEC16A', 'TIMP2', 'CDKAL1', 'MYO9B', 'GXYLT2', 'IGSF9B', 'ASAP2', 'ZNF257']",0.9999960853589026,0,0,12
394,Bile acids synthesis and enterohepatic circulation  WP4389,0.777350734100114,0.6963799143635656,0.175392776728885,['MAPK3'],0.9999960853589026,0,0,1
395,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.777350734100114,0.6963799143635656,0.175392776728885,['DHCR24'],0.9999960853589026,0,0,1
396,Disorders of Folate Metabolism and Transport WP4259,0.777350734100114,0.6963799143635656,0.175392776728885,['ALDH1L1'],0.9999960853589026,0,0,1
397,Estrogen metabolism WP697,0.777350734100114,0.6963799143635656,0.175392776728885,['CYP1B1'],0.9999960853589026,0,0,1
398,HIF1A and PPARG regulation of glycolysis WP2456,0.777350734100114,0.6963799143635656,0.175392776728885,['SLC2A1'],0.9999960853589026,0,0,1
399,Inflammatory Response Pathway WP453,0.777350734100114,0.6963799143635656,0.175392776728885,['THBS3'],0.9999960853589026,0,0,1
400,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.777350734100114,0.6963799143635656,0.175392776728885,['ZEB2'],0.9999960853589026,0,0,1
401,Mevalonate pathway WP3963,0.777350734100114,0.6963799143635656,0.175392776728885,['FDPS'],0.9999960853589026,0,0,1
402,NAD Biosynthesis II (from tryptophan) WP2485,0.777350734100114,0.6963799143635656,0.175392776728885,['TDO2'],0.9999960853589026,0,0,1
403,Pentose Phosphate Metabolism WP134,0.777350734100114,0.6963799143635656,0.175392776728885,['TKT'],0.9999960853589026,0,0,1
404,SRF and miRs in Smooth Muscle Differentiation and Proliferation WP1991,0.777350734100114,0.6963799143635656,0.175392776728885,['CAMK2D'],0.9999960853589026,0,0,1
405,Sulfation Biotransformation Reaction WP692,0.777350734100114,0.6963799143635656,0.175392776728885,['PAPSS2'],0.9999960853589026,0,0,1
406,Urea cycle and related diseases WP4571,0.777350734100114,0.6963799143635656,0.175392776728885,['SLC25A15'],0.9999960853589026,0,0,1
407,Valproic acid pathway WP3871,0.777350734100114,0.6963799143635656,0.175392776728885,['HADHB'],0.9999960853589026,0,0,1
408,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.7837084555072711,0.8028846153846154,0.1956775898707731,"['HSPA9', 'PSMC6', 'PSMC4', 'PSMD2', 'RNF19A', 'TUBB', 'SIAH1', 'CASK', 'UBE2L6', 'TUBB4A']",0.9999960853589026,0,0,10
409,PI3K-Akt signaling pathway WP4172,0.7842349483387656,0.8780791758401528,0.21341417975187382,"['PRKAA1', 'PHLPP1', 'FLT3', 'PDGFB', 'PPP2R2A', 'FGF2', 'THBS4', 'THBS3', 'RPTOR', 'IKBKB', 'PPP2CA', 'GYS1', 'PPP2R1B', 'FGF9', 'PPP2R1A', 'AKT2', 'THEM4', 'ITGB8', 'JAK1', 'MAPK3', 'PDGFRA', 'NTRK2', 'MAP2K1', 'CHUK', 'PDPK1', 'BAD', 'INSR', 'PPP2R5D', 'PPP2R5C', 'EFNA3', 'CDK6', 'RPS6KB1', 'PPP2R2B', 'SGK1', 'RAF1', 'TP53']",0.9999960853589026,0,0,36
410,Differentiation of white and brown adipocyte WP2895,0.7843436166307708,0.6962616822429907,0.16912758014823906,"['ZNF423', 'SMAD5']",0.9999960853589026,0,0,2
411,Kennedy pathway from sphingolipids WP3933,0.7843436166307708,0.6962616822429907,0.16912758014823906,"['PCYT1A', 'CEPT1']",0.9999960853589026,0,0,2
412,Pyrimidine metabolism and related diseases WP4225,0.7843436166307708,0.6962616822429907,0.16912758014823906,"['RRM2B', 'DPYS']",0.9999960853589026,0,0,2
413,SARS coronavirus and innate immunity WP4912,0.7843436166307708,0.6962616822429907,0.16912758014823906,"['DDX58', 'JAK1']",0.9999960853589026,0,0,2
414,Parkinson's disease pathway WP2371,0.7914887719380714,0.7457532720690615,0.1743866360730609,"['PINK1', 'LRRK2', 'UBE2L6', 'MAPK14', 'MAPK13']",0.9999960853589026,0,0,5
415,Differentiation Pathway WP2848,0.8007711535297206,0.6961433580054538,0.15466918258443763,"['PDGFB', 'FGF2', 'WNT2']",0.9999960853589026,0,0,3
416,Fatty Acid Biosynthesis WP357,0.8007711535297206,0.6961433580054538,0.15466918258443763,"['ACLY', 'PC', 'ACSL5']",0.9999960853589026,0,0,3
417,Type II interferon signaling (IFNG) WP619,0.8007711535297206,0.6961433580054538,0.15466918258443763,"['IRF2', 'IFIT2', 'JAK1']",0.9999960853589026,0,0,3
418,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.8126030463916218,0.7590660705414803,0.15751573325364257,"['CACNB2', 'SGCD', 'CACNB4', 'LMNA', 'ITGB8', 'DMD', 'CTNNA2', 'CACNG2']",0.9999960853589026,0,0,8
419,Nephrotic syndrome WP4758,0.8133094228770392,0.7199704241446528,0.148777314823297,"['SMARCAL1', 'LMNA', 'PMM2', 'MYH9', 'SYNPO']",0.9999960853589026,0,0,5
420,Interactome of polycomb repressive complex 2 (PRC2)  WP2916,0.816441840973595,0.6426431823628085,0.13032777954163047,"['SETX', 'EZH2']",0.9999960853589026,0,0,2
421,Mitochondrial complex III assembly WP4921,0.816441840973595,0.6426431823628085,0.13032777954163047,"['UQCC3', 'CYC1']",0.9999960853589026,0,0,2
422,Mitochondrial LC-Fatty Acid Beta-Oxidation WP368,0.816441840973595,0.6426431823628085,0.13032777954163047,"['SCP2', 'SLC25A20']",0.9999960853589026,0,0,2
423,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.816441840973595,0.6426431823628085,0.13032777954163047,"['ABCD2', 'ABCD3']",0.9999960853589026,0,0,2
424,Prion disease pathway WP3995,0.8175865926118383,0.696024941543258,0.14017835005103957,"['RAD21', 'EP300', 'FYN', 'MAPK3']",0.9999960853589026,0,0,4
425,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.8203639737541909,0.5968414613801925,0.1181788867806905,['WNT2'],0.9999960853589026,0,0,1
426,Blood Clotting Cascade WP272,0.8203639737541909,0.5968414613801925,0.1181788867806905,['F8A1'],0.9999960853589026,0,0,1
427,Iron metabolism in placenta WP2007,0.8203639737541909,0.5968414613801925,0.1181788867806905,['FTH1'],0.9999960853589026,0,0,1
428,Leptin and adiponectin WP3934,0.8203639737541909,0.5968414613801925,0.1181788867806905,['PRKAA1'],0.9999960853589026,0,0,1
429,Trans-sulfuration pathway WP2333,0.8203639737541909,0.5968414613801925,0.1181788867806905,['AHCY'],0.9999960853589026,0,0,1
430,Chemokine signaling pathway WP3929,0.8249141621732162,0.806021436456219,0.15513973679461082,"['MAP2K1', 'SHC3', 'CHUK', 'ROCK1', 'ARRB1', 'CX3CL1', 'ADCY5', 'TIAM2', 'RAP1B', 'IKBKB', 'TIAM1', 'GRK4', 'AKT2', 'RAF1', 'PLCB1', 'PLCB2', 'MAPK3']",0.9999960853589026,0,0,17
431,Unfolded protein response WP4925,0.8264335447436025,0.6594427244582043,0.12571337193550197,"['ATF6', 'TP53', 'NFE2L2']",0.9999960853589026,0,0,3
432,Cytosolic DNA-sensing pathway WP4655,0.8303524344762786,0.7157343436594606,0.13305862784683029,"['IKBKB', 'CHUK', 'POLR3B', 'DDX58', 'POLR3G', 'ATG5']",0.9999960853589026,0,0,6
433,PPAR signaling pathway WP3942,0.8303524344762786,0.7157343436594606,0.13305862784683029,"['CYP27A1', 'SCP2', 'PDPK1', 'ACSL5', 'SORBS1', 'CPT1C']",0.9999960853589026,0,0,6
434,Pyrimidine metabolism WP4022,0.8351292036219129,0.7704336320442654,0.13880812702180495,"['PRIM2', 'PNPT1', 'UCK1', 'RRM2B', 'POLR3B', 'DPYS', 'POLR2C', 'CMPK1', 'ENPP1', 'CMPK2', 'POLR3G', 'DCK']",0.9999960853589026,0,0,12
435,Cell cycle WP179,0.8422297356052345,0.7822896281800391,0.13432105110207895,"['SMAD2', 'TGFB2', 'CDC25B', 'MAD2L2', 'CCNA1', 'CCNB1', 'CDK6', 'STAG2', 'RAD21', 'ABL1', 'MCM3', 'EP300', 'ATM', 'TP53', 'ATR']",0.9999960853589026,0,0,15
436,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.844189989120586,0.5966844681797953,0.10106504530765721,"['PDGFB', 'FGF2']",0.9999960853589026,0,0,2
437,Statin inhibition of cholesterol production WP430,0.844189989120586,0.5966844681797953,0.10106504530765721,"['PDIA2', 'LRP1']",0.9999960853589026,0,0,2
438,Transcription factor regulation in adipogenesis WP3599,0.844189989120586,0.5966844681797953,0.10106504530765721,"['MAPK8', 'INSR']",0.9999960853589026,0,0,2
439,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.844189989120586,0.5966844681797953,0.10106504530765721,"['DDX58', 'JAK1']",0.9999960853589026,0,0,2
440,Urea cycle and metabolism of amino groups WP497,0.844189989120586,0.5966844681797953,0.10106504530765721,"['OAT', 'ALDH18A1']",0.9999960853589026,0,0,2
441,Oncostatin M Signaling Pathway WP2374,0.8446118754976326,0.7259274344092591,0.12259322849812851,"['MAP2K1', 'MAPK8', 'JUND', 'RAF1', 'MAPK14', 'TP53', 'JAK1', 'MAPK3']",0.9999960853589026,0,0,8
442,Energy Metabolism WP1541,0.8475342231667043,0.6957878315132605,0.11510004744841608,"['PRKAA1', 'PPP3CC', 'PRKAG2', 'EP300', 'MAPK14', 'CAMK2G']",0.9999960853589026,0,0,6
443,Eukaryotic Transcription Initiation WP405,0.8475342231667043,0.6957878315132605,0.11510004744841608,"['POLR3B', 'POLR2C', 'GTF2H1', 'TAF6', 'MNAT1', 'GTF2E1']",0.9999960853589026,0,0,6
444,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.8475342231667043,0.6957878315132605,0.11510004744841608,"['SMAD2', 'TGFB2', 'ICMT', 'MAOB', 'LMNA', 'RUNX2']",0.9999960853589026,0,0,6
445,Pre-implantation embryo WP3527,0.8492089092318705,0.6264121542656798,0.10238710287435697,"['ARGFX', 'CELF3', 'ATP1A1']",0.9999960853589026,0,0,3
446,15q11.2 copy number variation syndrome WP4940,0.8550700979567012,0.5221876216426625,0.08175987021417148,['NIPA1'],0.9999960853589026,0,0,1
447,Cancer immunotherapy by CTLA4 blockade WP4582,0.8550700979567012,0.5221876216426625,0.08175987021417148,['PPP2CA'],0.9999960853589026,0,0,1
448,Estrogen Receptor Pathway WP2881,0.8550700979567012,0.5221876216426625,0.08175987021417148,['CYP1B1'],0.9999960853589026,0,0,1
449,Genes targeted by miRNAs in adipocytes WP1992,0.8550700979567012,0.5221876216426625,0.08175987021417148,['HDAC4'],0.9999960853589026,0,0,1
450,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.8550700979567012,0.5221876216426625,0.08175987021417148,['MAPK3'],0.9999960853589026,0,0,1
451,Serotonin and anxiety-related events WP3944,0.8550700979567012,0.5221876216426625,0.08175987021417148,['PLCD4'],0.9999960853589026,0,0,1
452,Neural Crest Cell Migration during Development WP4564,0.8581231986843918,0.6423646501588824,0.0982866744681202,"['TIAM1', 'AKT2', 'PIK3R4', 'PAK2']",0.9999960853589026,0,0,4
453,Constitutive Androstane Receptor Pathway WP2875,0.8680705572228753,0.5568535825545171,0.0787849147656765,"['PTPA', 'NCOA6']",0.9999960853589026,0,0,2
454,Lung fibrosis WP3624,0.869334172000986,0.5965273526629195,0.08353034117781505,"['PDGFB', 'FGF2', 'NFE2L2']",0.9999960853589026,0,0,3
455,Photodynamic therapy-induced unfolded protein response WP3613,0.869334172000986,0.5965273526629195,0.08353034117781505,"['DNAJB9', 'ATF6', 'NFE2L2']",0.9999960853589026,0,0,3
456,"GPCRs, Class A Rhodopsin-like WP455",0.870530569734391,0.7285025772716277,0.1010086328919381,"['GPR27', 'OPRD1', 'GPR39', 'CHRM3', 'RABGAP1', 'GPR161', 'CHRM5', 'GPR63', 'ADORA1', 'GPR83', 'SSTR3']",0.9999960853589026,0,0,11
457,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.8742291717452557,0.679427270005172,0.09132367247403385,"['SMARCAL1', 'MYH9', 'FYN', 'SYNPO', 'VCL', 'NCK1', 'LRP6']",0.9999960853589026,0,0,7
458,Translation Factors WP107,0.8742291717452557,0.679427270005172,0.09132367247403385,"['EIF5A', 'EIF2B3', 'EEF2K', 'EIF2B2', 'EIF3CL', 'GSPT2', 'EIF4G1']",0.9999960853589026,0,0,7
459,Development and heterogeneity of the ILC family WP3893,0.8830729467792573,0.4641235240690282,0.05771258568673756,['RORA'],0.9999960853589026,0,0,1
460,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.8830729467792573,0.4641235240690282,0.05771258568673756,['TGFB2'],0.9999960853589026,0,0,1
461,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.8830729467792573,0.4641235240690282,0.05771258568673756,['FDPS'],0.9999960853589026,0,0,1
462,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.8868642641494678,0.66392366899585,0.07971289081385569,"['CTBP2', 'CHD8', 'SERPINF1', 'DVL1', 'WNT2', 'LRP6', 'EZH2']",0.9999960853589026,0,0,7
463,"Relationship between inflammation, COX-2 and EGFR WP4483",0.8885419630673803,0.5220015576323987,0.06168670063985834,"['AKT2', 'MAPK3']",0.9999960853589026,0,0,2
464,Toll-like Receptor Signaling related to MyD88 WP3858,0.8885419630673803,0.5220015576323987,0.06168670063985834,"['IKBKB', 'CHUK']",0.9999960853589026,0,0,2
465,TYROBP causal network in microglia WP3945,0.8885419630673803,0.5220015576323987,0.06168670063985834,"['RBM47', 'TGFBR1']",0.9999960853589026,0,0,2
466,Wnt Signaling Pathway WP363,0.8907061517317997,0.6420856834273371,0.07431544770687852,"['MAPK8', 'CDK6', 'DVL1', 'TCF4', 'MAP3K7', 'LRP6']",0.9999960853589026,0,0,6
467,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.892990647363459,0.7413208039676324,0.08390207436257494,"['CHRNB2', 'GABRA1', 'NTRK2', 'ATP1A3', 'RORA', 'ECE1', 'TACR1', 'HDAC9', 'HADHB', 'AR', 'PRKAR2A', 'BHLHE40', 'EP300', 'PKNOX1', 'PRKACA', 'CC2D1A']",0.9999960853589026,0,0,16
468,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.8935082893027492,0.6827233680025558,0.07687442394912108,"['YY1', 'ACLY', 'FDPS', 'PRKAA1', 'SEC24A', 'PRKAG2', 'SCAP', 'PRKACA', 'ATF6']",0.9999960853589026,0,0,9
469,Focal Adhesion WP306,0.8942535403828726,0.7731043479362184,0.0864067355553375,"['PDGFRA', 'MAP2K1', 'SHC3', 'ROCK1', 'PDPK1', 'BAD', 'TNK2', 'PDGFB', 'THBS4', 'THBS3', 'RAP1B', 'PPP1CC', 'MAPK8', 'AKT2', 'ZYX', 'ITGB8', 'FLNB', 'FYN', 'RAF1', 'PPP1R12B', 'PAK2', 'VCL', 'MAPK3']",0.9999960853589026,0,0,23
470,7q11.23 copy number variation syndrome WP4932,0.9001340490199382,0.7133771072185744,0.07505553500699795,"['ATPAF2', 'CLTC', 'UBE2L6', 'HDAC6', 'MLXIPL', 'BCL7B', 'ERCC6', 'WNT2', 'DLD', 'CLASP1', 'CLASP2', 'MAPK3', 'BRD4']",0.9999960853589026,0,0,13
471,Development of ureteric collection system WP5053,0.9025800394408043,0.544553784658119,0.055815622820521014,"['TGFB2', 'FAT4', 'ROBO1']",0.9999960853589026,0,0,3
472,Nuclear receptors WP170,0.9025800394408043,0.544553784658119,0.055815622820521014,"['AR', 'NR2F1', 'RORA']",0.9999960853589026,0,0,3
473,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.9025800394408043,0.544553784658119,0.055815622820521014,"['RPTOR', 'BAD', 'ATG13']",0.9999960853589026,0,0,3
474,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.9056668076134402,0.41767224601012065,0.041384554373604485,['SYTL3'],0.9999960853589026,0,0,1
475,FOXA2 pathway WP5066,0.9056668076134402,0.41767224601012065,0.041384554373604485,['MLXIPL'],0.9999960853589026,0,0,1
476,GDNF/RET signaling axis WP4830,0.9056668076134402,0.41767224601012065,0.041384554373604485,['FAT4'],0.9999960853589026,0,0,1
477,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969,0.9056668076134402,0.41767224601012065,0.041384554373604485,['TULP3'],0.9999960853589026,0,0,1
478,"NAD metabolism, sirtuins and aging WP3630",0.9056668076134402,0.41767224601012065,0.041384554373604485,['ROS1'],0.9999960853589026,0,0,1
479,ncRNAs involved in STAT3 signaling in hepatocellular carcinoma WP4337,0.9056668076134402,0.41767224601012065,0.041384554373604485,['JAK1'],0.9999960853589026,0,0,1
480,RalA downstream regulated genes WP2290,0.9056668076134402,0.41767224601012065,0.041384554373604485,['EXOC8'],0.9999960853589026,0,0,1
481,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.9056668076134402,0.41767224601012065,0.041384554373604485,['RAD21'],0.9999960853589026,0,0,1
482,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.9060298553802926,0.4912497709364119,0.04847801122758784,"['CBX5', 'TP53']",0.9999960853589026,0,0,2
483,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.9060298553802926,0.4912497709364119,0.04847801122758784,"['PDGFRA', 'RUNX2']",0.9999960853589026,0,0,2
484,Monoamine GPCRs WP58,0.9060298553802926,0.4912497709364119,0.04847801122758784,"['CHRM3', 'CHRM5']",0.9999960853589026,0,0,2
485,Apoptosis Modulation and Signaling WP1772,0.9126890641843196,0.6586448550114059,0.06017380802280828,"['IKBKB', 'PIDD1', 'DAXX', 'MAPK8', 'ENDOG', 'BAD', 'TP53', 'MAP3K14', 'MAPK3']",0.9999960853589026,0,0,9
486,Non-small cell lung cancer WP4255,0.9126890641843196,0.6586448550114059,0.06017380802280828,"['MAP2K1', 'CDK6', 'BAD', 'RASSF5', 'AKT2', 'POLK', 'RAF1', 'TP53', 'MAPK3']",0.9999960853589026,0,0,9
487,Intraflagellar transport proteins binding to dynein WP4532,0.9161556801824767,0.5218153486560188,0.04569483376932941,"['DYNC2H1', 'WDR60', 'IFT80']",0.9999960853589026,0,0,3
488,Prostaglandin Synthesis and Regulation WP98,0.9161556801824767,0.5218153486560188,0.04569483376932941,"['HSD11B1', 'ANXA6', 'PTGFRN']",0.9999960853589026,0,0,3
489,SARS-CoV-2 mitochondrial interactions WP5038,0.9209226748133297,0.4639148494288681,0.03821693607024743,"['DDX58', 'PHB2']",0.9999960853589026,0,0,2
490,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.9209226748133297,0.4639148494288681,0.03821693607024743,"['RASA1', 'FYN']",0.9999960853589026,0,0,2
491,Major receptors targeted by epinephrine and norepinephrine WP4589,0.9238961416901353,0.37966665487101453,0.03005274734343408,['ADCY5'],0.9999960853589026,0,0,1
492,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.9238961416901353,0.37966665487101453,0.03005274734343408,['PFKFB4'],0.9999960853589026,0,0,1
493,Copper homeostasis WP3286,0.9272830578872485,0.5385060216729942,0.04065527232129603,"['ADAM10', 'ADAM9', 'COMMD1', 'TP53']",0.9999960853589026,0,0,4
494,Glycerolipids and Glycerophospholipids WP4722,0.9335701492718453,0.4394572880800131,0.030207930247610097,"['PCYT1A', 'AGPAT4']",0.9999960853589026,0,0,2
495,Melatonin metabolism and effects WP3298,0.9382601476497587,0.4815858080369183,0.0306905126637591,"['PER2', 'CYP1B1', 'ECE1']",0.9999960853589026,0,0,3
496,Fatty acid transporters WP5061,0.9386037912922004,0.34799532892175944,0.022049623072801776,['ACSL5'],0.9999960853589026,0,0,1
497,"GPCRs, Class B Secretin-like WP334",0.9386037912922004,0.34799532892175944,0.022049623072801776,['ADGRL3'],0.9999960853589026,0,0,1
498,Omega-3/Omega-6 FA synthesis WP4723,0.9386037912922004,0.34799532892175944,0.022049623072801776,['PLA2G6'],0.9999960853589026,0,0,1
499,Omega-9 FA synthesis WP4724,0.9386037912922004,0.34799532892175944,0.022049623072801776,['ELOVL6'],0.9999960853589026,0,0,1
500,PPAR-alpha pathway WP2878,0.9386037912922004,0.34799532892175944,0.022049623072801776,['SCP2'],0.9999960853589026,0,0,1
501,Gastric Cancer Network 2 WP2363,0.9442837566485153,0.4174454828660436,0.023931551890465565,"['AHCTF1', 'TP53']",0.9999960853589026,0,0,2
502,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.9504698869577438,0.3211965146570051,0.01631639712986914,['PTGR2'],0.9999960853589026,0,0,1
503,Eicosanoid Synthesis WP167,0.9504698869577438,0.3211965146570051,0.01631639712986914,['PLA2G6'],0.9999960853589026,0,0,1
504,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.9504698869577438,0.3211965146570051,0.01631639712986914,['BCL2L13'],0.9999960853589026,0,0,1
505,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.9520649346287237,0.5214424951267057,0.0256143179943403,"['HELLS', 'JUND', 'RPS6KB1', 'ABL1', 'PAK2']",0.9999960853589026,0,0,5
506,Hematopoietic Stem Cell Differentiation WP2849,0.95333845217009,0.39753004005340453,0.018996090013324404,"['HMGN5', 'MXI1']",0.9999960853589026,0,0,2
507,Cholesterol Biosynthesis Pathway WP197,0.9600432494951434,0.29822610243007286,0.012160749071450573,['FDPS'],0.9999960853589026,0,0,1
508,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.9600432494951434,0.29822610243007286,0.012160749071450573,['NFE2L2'],0.9999960853589026,0,0,1
509,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.9600432494951434,0.29822610243007286,0.012160749071450573,['PRKAA1'],0.9999960853589026,0,0,1
510,Vitamin D-sensitive calcium signaling in depression WP4698,0.9614965925781891,0.4316456886476902,0.01694824760596294,"['CYP27A1', 'ITPR1', 'NFE2L2']",0.9999960853589026,0,0,3
511,Apoptosis WP254,0.9642169977386025,0.5404690683660641,0.019694102829022817,"['IKBKB', 'HELLS', 'MAP3K1', 'CHUK', 'BAD', 'IRF2', 'TP53']",0.9999960853589026,0,0,7
512,Allograft Rejection WP2328,0.9672068823385254,0.41721854304635764,0.013911261127495,"['PDGFRA', 'C5', 'LRRK2']",0.9999960853589026,0,0,3
513,Glycosylation and related congenital defects WP4521,0.967403632980874,0.36289448733577134,0.01202612850606403,"['PMM2', 'MGAT2']",0.9999960853589026,0,0,2
514,Kallmann's Syndrome WP5074,0.9677667333081152,0.2783184118333982,0.009118879756335935,['FRS2'],0.9999960853589026,0,0,1
515,Microglia Pathogen Phagocytosis Pathway WP3937,0.9677667333081152,0.2783184118333982,0.009118879756335935,['PIK3C2A'],0.9999960853589026,0,0,1
516,Pregnane X receptor pathway WP2876,0.9677667333081152,0.2783184118333982,0.009118879756335935,['NCOA3'],0.9999960853589026,0,0,1
517,Selenium Micronutrient Network WP15,0.9681342111338974,0.48492678725236865,0.015704137461445965,"['SELENOS', 'INSR', 'PNPO', 'HBA1', 'SOD2']",0.9999960853589026,0,0,5
518,DNA Repair Pathways Full Network WP4946,0.9682237505025769,0.6310265077388365,0.020377152918602332,"['FANCM', 'XPA', 'RPA2', 'GTF2H1', 'PALB2', 'RAD23B', 'RAD54B', 'CUL4A', 'SMUG1', 'RAD52', 'ATM', 'POLK', 'ERCC6', 'MNAT1', 'ATR']",0.9999960853589026,0,0,15
519,DNA Replication WP466,0.972110305458251,0.4037221810322078,0.011419684796619164,"['PRIM2', 'MCM3', 'RPA2']",0.9999960853589026,0,0,3
520,Alpha 6 Beta 4 signaling pathway WP244,0.9728055512804943,0.3477414330218069,0.009587600362672501,"['MAPK14', 'MAPK3']",0.9999960853589026,0,0,2
521,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.9735942924848638,0.4390203880707224,0.011748448823729647,"['CYP27A1', 'FDPS', 'MYLIP', 'DHCR24']",0.9999960853589026,0,0,4
522,Mitochondrial Gene Expression WP391,0.9739976799142882,0.2608991825613079,0.006873743098854784,['MYEF2'],0.9999960853589026,0,0,1
523,Nanomaterial induced apoptosis WP2507,0.9739976799142882,0.2608991825613079,0.006873743098854784,['ENDOG'],0.9999960853589026,0,0,1
524,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.9739976799142882,0.2608991825613079,0.006873743098854784,['EIF3CL'],0.9999960853589026,0,0,1
525,Purine metabolism and related disorders WP4224,0.9739976799142882,0.2608991825613079,0.006873743098854784,['RRM2B'],0.9999960853589026,0,0,1
526,Complement system WP2806,0.9763128214714437,0.39106934164394236,0.009374804250731061,"['C5', 'SERPING1', 'PRKACA']",0.9999960853589026,0,0,3
527,Adipogenesis WP236,0.9782315808099875,0.5656578814062206,0.0124494776437101,"['WWTR1', 'BMP3', 'MBNL1', 'KLF5', 'DVL1', 'ASIP', 'LMNA', 'NR2F1', 'RORA', 'KLF15', 'AGT']",0.9999960853589026,0,0,11
528,Apoptosis Modulation by HSP70 WP384,0.9790244248937268,0.24552927438005176,0.005204898468679609,['MAP3K1'],0.9999960853589026,0,0,1
529,Globo Sphingolipid Metabolism WP1424,0.9790244248937268,0.24552927438005176,0.005204898468679609,['ST6GALNAC5'],0.9999960853589026,0,0,1
530,Immune response to tuberculosis WP4197,0.9790244248937268,0.24552927438005176,0.005204898468679609,['JAK1'],0.9999960853589026,0,0,1
531,Nucleotide metabolism WP404,0.9790244248937268,0.24552927438005176,0.005204898468679609,['RRM2B'],0.9999960853589026,0,0,1
532,Ovarian infertility WP34,0.9790244248937268,0.24552927438005176,0.005204898468679609,['ATM'],0.9999960853589026,0,0,1
533,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.9790244248937268,0.24552927438005176,0.005204898468679609,['DLD'],0.9999960853589026,0,0,1
534,mRNA Processing WP411,0.9815714929434957,0.6053961700007119,0.011260627523926604,"['SRPK2', 'RBM39', 'TMED10', 'SF3B3', 'RNGTT', 'SFSWAP', 'DDX1', 'NONO', 'CELF2', 'SRSF1', 'SUPT5H', 'PRPF8', 'PRPF3', 'SPOP', 'DHX38', 'RBM5']",0.9999960853589026,0,0,16
535,Striated Muscle Contraction Pathway WP383,0.9830796192767988,0.23186713377449072,0.003956851105216669,['DMD'],0.9999960853589026,0,0,1
536,Vitamin A and carotenoid metabolism WP716,0.9843096659479221,0.30901696088611974,0.004887019885677543,"['RETSAT', 'RDH10']",0.9999960853589026,0,0,2
537,Myometrial relaxation and contraction pathways WP289,0.9876599602703506,0.5656517313156175,0.0070235902103114485,"['RGS17', 'CAMK2D', 'ITPR1', 'ARRB1', 'ADCY5', 'RGS2', 'CALD1', 'GRK4', 'PRKAR2A', 'GNAS', 'NOS1', 'PRKACA', 'CAMK2G', 'RGS6']",0.9999960853589026,0,0,14
538,Proteasome Degradation WP183,0.9882875117744748,0.4167641325536062,0.004910156534080643,"['PSMB4', 'PSMA4', 'PSMC6', 'PSMC4', 'PSMD2']",0.9999960853589026,0,0,5
539,Mitochondrial CIV Assembly WP4922,0.9910221151251584,0.2780373831775701,0.0025074603807007717,"['SURF1', 'CMC1']",0.9999960853589026,0,0,2
540,DNA Mismatch Repair WP531,0.9911187816235104,0.19868764944669967,0.0017724709567494491,['RPA2'],0.9999960853589026,0,0,1
541,Mitochondrial complex I assembly model OXPHOS system WP4324,0.9981988023740995,0.2658869945047203,0.0004793468521785563,"['NUBPL', 'NDUFAF7', 'NDUFS4']",0.9999960853589026,0,0,3
542,Base Excision Repair WP4752,0.9984075839257693,0.14376988228345927,0.00022912395032526314,['SMUG1'],0.9999960853589026,0,0,1
543,Small cell lung cancer WP4658,0.998981845386914,0.34194217083751843,0.00034832735430430584,"['IKBKB', 'CDK6', 'CHUK', 'AKT2', 'POLK', 'TP53']",0.9999960853589026,0,0,6
544,Oxidative phosphorylation WP623,0.9997674444895196,0.1699249793375294,3.9521585972649705e-05,"['ATP6AP1', 'NDUFS4']",0.9999960853589026,0,0,2
545,Nonalcoholic fatty liver disease WP4396,0.9999284038857551,0.34864101890756305,2.496223583037126e-05,"['IKBKB', 'VMP1', 'MLXIPL', 'PRKAA1', 'MAPK8', 'AKT2', 'INSR', 'NDUFS4', 'PRKAG2', 'CYC1']",0.9999960853589026,0,0,10
546,Cytoplasmic Ribosomal Proteins WP477,0.9999286085222042,0.2533637617077925,1.8088659063950953e-05,"['RPS6KA3', 'RPS6KA6', 'RPS6KB1', 'RPLP0', 'RPS11']",0.9999960853589026,0,0,5
547,Electron Transport Chain (OXPHOS system in mitochondria) WP111,0.9999960853589026,0.09762690122778084,3.8217502779674027e-07,"['SURF1', 'NDUFS4']",0.9999960853589026,0,0,2
